ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000434.1|SW-163_1 # 3 # 752 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=CCA;rbs_spacer=13bp;gc_cont=0.664	BGC0000434.1|SW-163_1 	3	752	-	Loose	1000	26.9498	vga(E) Staphylococcus cohnii	37.5	3004715	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGACCCACAAGGACGCGACCGAGGGCGGCTCGACCGAGCGCATACCCCCCAACGCCAAACCCTCCGATGTCATCCCCGGCAGCCCCACCGACGTCGAAGACCTGGCCGTCAAACTCCGCGCCTACGCGAGCGCGTTCCAGGACGGGGTCGAACAACTCGACGTGCTGTCCCTGATGAACTGGACCGGTGCGGCATCGGAGGGATTCCAGGGCGCGACGGAGAAGCTGCCCAAGGAACTGGGCTCGGCCAAGACCTACTTCACCTCCGCCGCCAGTGCGCTGGATTCCTATGCGGGAAAGCTGCGGTCGGTACAAAAGCGCGTCAAGCCCATCATCGACGACGCCGATGACGCACGGGCGGCATCCAAGCGCTACTGGCAGCAGGTGAAGGACTACGCCGACGCGGAGGACCGCAAGGACGATCCCCTGCCGGAGAAGCCCCCGGAGGACGATCCGGGGATGGCCGCTTTGAACGCCTGCTACAAGCGCCTGGACAAGCTGGAGAAGGAACTCAACCTCGTCGTCGACACGGCCAAGCGCACACTCGACACCGCCAAGGAGAAGGCCCCGGACAAGCCCCCGGCTCCCGAAGGCATGGACTACCTCAAGCAGAAGTGGGGGGACTTCTTCGGCGGCGCGAAGGACACCGCGCACGGGTGGTACAAGGAGTTCGAGTATCTCGTCGAGGACGGGCCCCAGGGGGCCGGGCTGCGGCTTGCGGGCATGGCAGACGGGGCCGCCTACGCCGTG	MTHKDATEGGSTERIPPNAKPSDVIPGSPTDVEDLAVKLRAYASAFQDGVEQLDVLSLMNWTGAASEGFQGATEKLPKELGSAKTYFTSAASALDSYAGKLRSVQKRVKPIIDDADDARAASKRYWQQVKDYADAEDRKDDPLPEKPPEDDPGMAALNACYKRLDKLEKELNLVVDTAKRTLDTAKEKAPDKPPAPEGMDYLKQKWGDFFGGAKDTAHGWYKEFEYLVEDGPQGAGLRLAGMADGAAYAV	MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE	47.71	gnl|BL_ORD_ID|2247|hsp_num:0	3400			615	735	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin; valnemulin
BGC0000434.1|SW-163_2 # 749 # 1303 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000434.1|SW-163_2 	749	1303	-	Loose	700	24.2534	Klebsiella pneumoniae KpnH	29.17	3004597	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGGGGGATGACAAGGGTGGTTCGGCGGCGGATGGGCCGAAGCCGGGTGATGGCTACCGGGTGGAGATCGATTCGGTACAGAAGGTGCTGACGCCGCTGGAGGAGTCGGTCGTCGCCGCGCGGAAGATCAAGAAGGACTGGAAGACGCTGGCCGAGAGCATCGGGACCTCCGCCGACTTCGACATCTACGACTCCTCGGAGAAGTTGCTCTCCGCCTGGGGGTTCGGCATGGGGCGGGTGGCTGAGCACGCGGACACGGTGGTGCAGACCCTCCGGCAGGTGATCGCCGCCTACATGCTCGCCGACCTGCTGCGCATCAAGGACTTCGCGCCGACCGAGGACAACATGGCCAAGCTCCCCTTCGGCGAATACGGCATGAAGGCGTGGAAGGACGGCTACCGGCCGAAGTTCGATCCACCGCCGGAGATCTACAAGGAACCGTGGCTCGACGACGACGGCACCACCGTCACCGGAGAGGTGCCCACCAACCCGCGGCTTCGCTACGACGGCGGCTGGGAAGTCGACGGCGGTTCCAAGGGAGTGACCGCATGA	MSGDDKGGSAADGPKPGDGYRVEIDSVQKVLTPLEESVVAARKIKKDWKTLAESIGTSADFDIYDSSEKLLSAWGFGMGRVAEHADTVVQTLRQVIAAYMLADLLRIKDFAPTEDNMAKLPFGEYGMKAWKDGYRPKFDPPPEIYKEPWLDDDGTTVTGEVPTNPRLRYDGGWEVDGGSKGVTA	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH	35.94	gnl|BL_ORD_ID|2732|hsp_num:0	3299			1071	1281	erythromycin; gentamicin C; ciprofloxacin; spectinomycin; streptomycin; tobramycin; ceftazidime; ertapenem; piperacillin; azithromycin; imipenem; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; norfloxacin; ticarcillin; gentamicin
BGC0000434.1|SW-163_4 # 2099 # 3097 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=CCA;rbs_spacer=15bp;gc_cont=0.731	BGC0000434.1|SW-163_4 	2099	3097	-	Loose	2090	25.409	smeB	30.3	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGCGTTGACCATACCTCTGTGTCGGCAGTTGGGGATCGAGGTGCCCGTGGTGCAGGCGCCCATCGGGTCTGCGGTCACAACAGACCTGGTGGCTGCGGTGGCGGACGCGGGCGGGCTCGGCACCCTCGCCCTGACGTGGGTCACCCCGGAAGAGGCGGTGCGCCGGATCCGGGTGGTGCGGCGGTTGACGCCGAGGCCCTTCGCCGTGAACTTGGTGCTGGACTTCCCGGTCGACGAGCTTCTCGACGCCTGCCTGGCGGAAGGGGTGCCGATCATCTCGACGTTCTGGGGTGATCCCTCGGCTGTCGCCGAACGCACGCACTCGGCCGGCGCCATTCACCTCCACACGGTCGGTTCCGTCGCCGAGGCCGAACGCGCCGTTGCCGCAGGCGTCGATGTGATCGTGGCCCAGGGGTGTGAAGCAGGCGGCCACGTGCGCGGGGAGACCACCACGATGGCGCTCGTGCCCGCGGTCGTGGACGCTGTGCACCCGGTGCCCGTCATCGCGGCCGGCGGCATTGCCGACGGGCGCGGGCTCGCCGCCGCACTGGCTCTCGGGGCCCAGGCCGGATGGCTGGGCACCCGATTCCTGGCGGCCTACGAGGCAGCCACACACGAGGTCTACCGCCAAGCCGTGATCCGGGCGGCTCCGCAGGACGCGGTGCACACGCGGTGCTTCGACGGTGGCTGGCCCAACGCCCCGCATCGCGCACTGCGCAACGCCACGCTCAGCGCCTGGGAGGCCGCGGGCTGTCCCGCCGCGCCGAACCGTCCCGGAGAGGGCGCCGTGGTGGCCCGCAGCGCCGAGGGGCGGACCTGGTCGCGTTACGAGGACATGGTCCCCGTGCCCGGCATGTCGGGCGACCTGGAGGCTCTTGCCCTCTACGCGGGCCAGAGCGCCGGGCTCGTCCACGACGTCGCCCCGGCGGGCCGCATCGTGGCCGACATCGCCGCTGGTGCCGCGGCCCTCTTGGGGCCGACGCGGACACCCTGA	MTALTIPLCRQLGIEVPVVQAPIGSAVTTDLVAAVADAGGLGTLALTWVTPEEAVRRIRVVRRLTPRPFAVNLVLDFPVDELLDACLAEGVPIISTFWGDPSAVAERTHSAGAIHLHTVGSVAEAERAVAAGVDVIVAQGCEAGGHVRGETTTMALVPAVVDAVHPVPVIAAGGIADGRGLAAALALGAQAGWLGTRFLAAYEAATHEVYRQAVIRAAPQDAVHTRCFDGGWPNAPHRALRNATLSAWEAAGCPAAPNRPGEGAVVARSAEGRTWSRYEDMVPVPGMSGDLEALALYAGQSAGLVHDVAPAGRIVADIAAGAAALLGPTRTP	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	31.65	gnl|BL_ORD_ID|1813|hsp_num:0	1960			2355	2640	
BGC0000434.1|SW-163_5 # 3609 # 4988 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	BGC0000434.1|SW-163_5 	3609	4988	-	Loose	880	32.3426	tet(L)	24.44	3000179	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGATATCTATAGCATCGCGGGTGTTTTCGCGAATAAGCCACAAAATGACGTTCGCCACGTGGCGTCAACCACGGGCGATCCTGTGGGCCACCGCGGGTGTGGCGGCCCTCGCATTGCTCATCGCGCTGGAGATCGCCGCGCGTCGCTACGGCGGCCAACCGGGGCCGATTACCAACCAGGCGCGAGAGGTGATATTCGCGCCCAAACCCGGGCCGCTGTACGGCGGTCTGGCGTTGATGATGGTGGTGCTCACCTGGCGGCAGCGGTTCATCGCGACCGGTGTCGCGATCGGCATCGACGTCGTCTTCGTGCTGGTGCGGTGGGCGGTCGACGCGAAGGCGCCCGAGGGCGAATCTTTTGGCAACGGCGCGTTGTGGGTGATGTTGGGCTATGCGGTCATCGCGATCACACGCCGCACGGGCCAGGAACGCACTCTGCTGCTGAAGGGTGTCGGGCTGGGTCTGCTGCTGGTGGCCGGCCGTAAGACCGGCGATACCTGGCTGCTCATCACGTCGAAGACCCGCCCGACGGTGCTCGACCAGTACGTGGCGACCGCCGATCACGCGCTGGGCAATCCGTCGTGGCTGGTGGGCCGGATCGTCAAGGCCACCGACCCGATCAGCACCTTTGTTCTCGATGACTTGGTCTACGGTGAGCTTGCGGTGGCCGCGGTCGTCGTCGCGCTGTACCAGCTGCGCAACGTGGCGGTCGAGCGACGCTTCCCGAGCCATCATCTGTTGCGCACTTTTCTGGTGATCGGCCTTGTCGGGCCGGCTATCTACATGATCTTCCCCGTGGTCGGACCGATCTTCGCCTACGGCCCGGGTACCTCCGGCACCGGCGGCGTGCAATGGGCGGCGGCCGACCTGTGGCCGCACACACCGCCGCCGATCAGCATCCCGCACCCGATGCCGTACGACGGGATCACCCCACGCAACTGCATGCCCAGCCTGCACACGGCATGGGCTACCGCGATCTTCATTCACTCCCGCAAGGGCCCACGGATTCTGCGCTACGCGGGCACCTTCTGGCTGATCGCCACGCTCAGCGCGACGCTCGGCTTCGGCTACCACTACGGCGTGGATCTCATTGCCGGCGTGGTGTTCACGCTCACGATCGAGGCAGCGCTGCGCGCGTTCGACCGTGGCTGGGACCGGTCAGCAATCCAGCTGGTCGCTTACGGCACAACGGTCTTCGCCGCGCTCCTGGTGTCCTATCGCTATCTGCCGATGGAAATGGCCCAGCATCCGTGGGTGTTCGGACCCCTTCTCCTTCTGGCGATGGCCTCAGTGATCTACAGCTACCTGCGGACCACCAAACTGTGGGAAGGCAGGACCGCGCCAGCGCTGCAACCGGAACCGCAACCCGAACTGGTGTGA	MISIASRVFSRISHKMTFATWRQPRAILWATAGVAALALLIALEIAARRYGGQPGPITNQAREVIFAPKPGPLYGGLALMMVVLTWRQRFIATGVAIGIDVVFVLVRWAVDAKAPEGESFGNGALWVMLGYAVIAITRRTGQERTLLLKGVGLGLLLVAGRKTGDTWLLITSKTRPTVLDQYVATADHALGNPSWLVGRIVKATDPISTFVLDDLVYGELAVAAVVVALYQLRNVAVERRFPSHHLLRTFLVIGLVGPAIYMIFPVVGPIFAYGPGTSGTGGVQWAAADLWPHTPPPISIPHPMPYDGITPRNCMPSLHTAWATAIFIHSRKGPRILRYAGTFWLIATLSATLGFGYHYGVDLIAGVVFTLTIEAALRAFDRGWDRSAIQLVAYGTTVFAALLVSYRYLPMEMAQHPWVFGPLLLLAMASVIYSYLRTTKLWEGRTAPALQPEPQPELV	MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFMLTFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAFPALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITIITVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHIRKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIFPGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLGGLLFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPMEVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF	100.22	gnl|BL_ORD_ID|2349|hsp_num:0	1897			951	1356	tetracycline
BGC0000434.1|SW-163_6 # 5188 # 5550 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.625	BGC0000434.1|SW-163_6 	5188	5550	-	Loose	550	25.409	LRA-12	26.92	3002511	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGGAGTTCTACAAGGAGGCCCTCGGCGGCGACCTGGCCGTCCACACCTACGGCGCATTCGGCTCCGAGGCGCCACCCGGATACGCCGACAAGATCATGCACAGCATGCTCGAGACCCCCAGCGGATTCACACTGATGGGCGCCGACAATCCGCCCGGCACCGAACACAAACCCGGGAACAACTTCGCGGTGAGCCTGAGTGGCGACGACGCGGATGAACTGCGCGGCTACTGGGACAAGCTGTCCGACGGCGGCACCGTGTCCGTTCCGCTGAAAAAGCAGATGTGGGGCGACGTGTTCGGCATGTGCACGGACAAGTTCGGTATCACGTGGATGGTCAACATCAACGAGCAGCAGACCTGA	MEFYKEALGGDLAVHTYGAFGSEAPPGYADKIMHSMLETPSGFTLMGADNPPGTEHKPGNNFAVSLSGDDADELRGYWDKLSDGGTVSVPLKKQMWGDVFGMCTDKFGITWMVNINEQQT	MNVQNCMVKAVSVSIILFASLSLAAQKVKEPTVSNADWSKPYRPFRIAGNLYYIGTYDLACYLITTKQGNIIVNTGLAASALQIKNNIKALGFKLTDTKILLTTQAHYDHLGAMAEIKKITGAKLMADEGDATVMADGGSSDYAFGGHGSMFEPIIADRLLHDKDTIQLGDTKLVMLHHPGHTKGSCSFLFDTKDEQRSYRILIANMPTIVIEKKFSEVSSYPGIAKDYAYTLQAMKNLSFDIWVASHASQFSMHSKHKPGDGYNPKSFMDRKGYDESLDKLQKEYEKHLNEN	40.96	gnl|BL_ORD_ID|9|hsp_num:0	13			426	645	
BGC0000434.1|SW-163_7 # 5771 # 6094 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.645	BGC0000434.1|SW-163_7 	5771	6094	-	Loose	2200	24.6386	rpoB2	29.27	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGGCGGGCACACTGGGCTTCGGCCTGATGACACCGGCGGCGTCTGCCGCTGCCAGCGGCCCCTGCTACGACGGGCGGTGCAAGACCACCGTATCGGCGCCCAAAACCATCAAGGTCAACAGCCGCACGTTCGGATTCGGCACGTTGAAGATCACGCACATCAGCTCCCACTCCGTGAAGATGGCGGCCGTCACCACGGACGGAGCGCACCTGAGTGGCACCACCAGTCCGGGCGGCACCATCACATTCAACAACCTGGAGATCTGGGTGAAGTCGGTCTCCGGCCACAAGGCCAAGCTCCACCTGTCCCCCACGTCCTCCTGA	MAGTLGFGLMTPAASAAASGPCYDGRCKTTVSAPKTIKVNSRTFGFGTLKITHISSHSVKMAAVTTDGAHLSGTTSPGGTITFNNLEIWVKSVSGHKAKLHLSPTSS	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	9.21	gnl|BL_ORD_ID|2431|hsp_num:0	2831			2328	2451	rifampin; rifaximin; rifabutin; rifapentine
BGC0000434.1|SW-163_8 # 6132 # 6275 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.611	BGC0000434.1|SW-163_8 	6132	6275	+	Loose	1500	21.9422	rphA	37.93	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGCCCGTATTCATCAGTTGGACCTCCTGTTTTCAAGGGTTGATTCCCGCGAACTTTTCTAACCCGCCGGTCCGGGGACCCCTCCCGAACGGCGCGCGCGATGACGTGGCGGACCACGCGAATGACCTAGGACCAGGGGTCTGA	MPVFISWTSCFQGLIPANFSNPPVRGPLPNGARDDVADHANDLGPGV	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	5.43	gnl|BL_ORD_ID|890|hsp_num:0	910			1755	1839	rifampin; rifaximin; rifabutin; rifapentine
BGC0000434.1|SW-163_9 # 6412 # 7356 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0000434.1|SW-163_9 	6412	7356	+	Loose	500	26.5646	ErmH	26.03	3002823	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCCGAGCAGACGACACAACGGGCCGGTGCCTGGCCACGGCTCCGCGTGGCGGACTGGGCCGAGGCCCGGGACACACTCCACATGTGGACCCAGATCGTCGGCAAGATCCGGCTGGCCCATGCCCCACTGGCCAACCACTGGTGGCAGGTCACCCTGTACGTCACCCCGCGAGGGTTGAGCACATCCGCGATCCCTTACCGGACCGGTGCGTTCGACATCGAATTCGACTTCATCGACCACCGGCTGCGCATACGCGTCAGCGACGGAAGCAGCCGCGAGCTGGCGCTGGAGTCCAAACCGGTGTCCCAGTTCTACGCCGAGGTCATGGGGGCCCTGGGAGAACTCGGCATCCAGACCCGCATACACCCTCGCCCGAACGAGGTGGACCCGGCGATCCCGTTCGCGGAGGACCACCGCCACGCGACATATGACCCGCACGGCGCGCACCTCTTCTGGGGCCAGCTCACGCGGGCGGACCAGGCTTTTGAGGAATTCCGGTCCGAGTTCGTCGGCAAGGCCAGCCCCGTGCACTTCTTCTGGGGCTCCATGGATCTGGCCACCACCCGCTTCTCCGGCCGCCCCGCACCACCGCATCCCCCCGACGGCATGCCCAACCTGCCGGACTGGGTGACCAGGGAGGCTTACTCGGTCGAACTGTCCAGCTGCGGCTTCTGGCCCGGCGGCGGCGAGGAGGGCGCGTTCTACGCCTACGCCTACCCCGAGCCGGCCGGTCTCGCCGACCGCCCGATCCGCCCCGCCGCCGCGTCCTACCAGCGGGAATCCGGTGAATTCGTGCTGCCCTACGAGGCGGTCGCCACCGCCCCCGATCCGGACCGGGCGCTGAGTGAATTCCTGCACACCACCTACGCGGCAACCGCCGAACTGGCCCACTGGGACCGCGCGAGGTTGGAAGCAGGCCCCCACCGTTGGGAACACCACTGA	MAEQTTQRAGAWPRLRVADWAEARDTLHMWTQIVGKIRLAHAPLANHWWQVTLYVTPRGLSTSAIPYRTGAFDIEFDFIDHRLRIRVSDGSSRELALESKPVSQFYAEVMGALGELGIQTRIHPRPNEVDPAIPFAEDHRHATYDPHGAHLFWGQLTRADQAFEEFRSEFVGKASPVHFFWGSMDLATTRFSGRPAPPHPPDGMPNLPDWVTREAYSVELSSCGFWPGGGEEGAFYAYAYPEPAGLADRPIRPAAASYQRESGEFVLPYEAVATAPDPDRALSEFLHTTYAATAELAHWDRARLEAGPHRWEHH	MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR	105.02	gnl|BL_ORD_ID|1100|hsp_num:0	1193			639	858	erythromycin; lincomycin; pristinamycin IC; oleandomycin; carbomycin
BGC0000434.1|SW-163_10 # 7413 # 7958 # 1 # ID=1_10;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000434.1|SW-163_10 	7413	7958	+	Loose	730	24.2534	tet(G)	30.26	3000174	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGGGCCTCGCCACGGTGTCAGAACCTGGGCGGAGGTGGTCGGAGTGGAGCCCAGGATCAAGGACTGTCCGCTGGCCAGGACCGTGCTCGCCGTACAGCAGTGGTGGACGCTGGAGCTGCTGCACGAGGTGTTCGACGGGTTCACCGAACCCGGTGAGATCCGGGAGAACCTCGGGCTGTCCGACGAGGTACTCGCCGGGCAACTGGACGCCCTGGAGGAGCGGGGGCTGCTGATGCGGGCGGATGACGGCCGGTACGGGGCGACGGAGCTCGGGTGGTCGCTGCGGCCCGTCATCCTGGCGATGGCGGCGTGGGGCAATCGTGGGCTCGCCGCCCGCGAGCGGAGCCTGATCCTGGTCGACGCCGCCACCGGGGCGGAGGTCGAGCCCGTGGTGGTGGACTCCGCCAGTGGGGTGCGGGTGGATTCCGAGGCGTTCCGTTTCACCGCCGGGCCCGCGGCCAGCGAGCCGCTGCGGATCAAATACGGGAAGAAGGGCCTGTCACCCGGCAGCGGTGACGCCGCCCCGCCTCGGCATTCCGCCTGA	MGPRHGVRTWAEVVGVEPRIKDCPLARTVLAVQQWWTLELLHEVFDGFTEPGEIRENLGLSDEVLAGQLDALEERGLLMRADDGRYGATELGWSLRPVILAMAAWGNRGLAARERSLILVDAATGAEVEPVVVDSASGVRVDSEAFRFTAGPAASEPLRIKYGKKGLSPGSGDAAPPRHSA	MRSSAIIALLIVGLDAIGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVCAPLLGQFSDGYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLISGITGATGAVAASTIADSTGEGSRARWFGYMGACYGTGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETNRSHGETGKLVRIEPFVLFRLDDALRGLTALFAVFFTIQLIGQVPAALWVIYGEDRFQWDTTTVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATIGAWTGWVWIVGAILYLICLPILRRPFATSL	46.29	gnl|BL_ORD_ID|893|hsp_num:0	957			768	966	tetracycline
BGC0000434.1|SW-163_11 # 8010 # 9257 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	BGC0000434.1|SW-163_11 	8010	9257	-	Loose	700	26.9498	CMY-127	33.33	3003135	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGCAGCATCGGCGCCAGCATCAGCGTCGGCGGAGTTCCCACCGGCGGCCGGAATCCCACCGTCGTGCCTGCACGATGTGTTCCGCGCCGCCGATGCCCTGGAGCGCGACACCGGCCGCCCGGTGAACCAACTGCACGTCGGCGAGCCCTCGTTCCGCATGCCGCCAGAGGTGGCCGAGGGGCTGACCAAGGCGATCACGGACGGCCGCACCTCCTATACGTCGGCCGAAGGCATGCCACAGCTCCGGGAGGCACTGACCGCCAAGCTGGAGACGGAGAACGGGCATCACACCACCCCCGACCGGGTGTTCGTCTCTCCGGGTTCGTGCCAGGGCCTCGCCGCGCTGCTTCAGTCCATCGCCACGCCGGGCGCCGAACTGCTGCTGCCGGAGGTGCACTGGCCGATTCACCTTCAACAGGCGCTGCTGGCCGGATTCCGCCCGGTGTTCTATCCGCTCCGGGCCGACCTCGGTGTCGACATCGAGCGGCTCGCGGAGGTATCCGGGCCGCGCACCCGCGCGATCGTGGTGAACACACCCTCGAACCCCACCGGAGCCGTACTGGAGGAGGCCGAGCTGCGGCGGCTGCTCGCGCTCGCCGAGGAGCACGACTGGTACGTGATCAGCGACGAGGCGTACGAACACTTCGTCTACGAGGGACAGCATGTGTCGCTGGCCTCGCTGGAACGGGACCTGCCACCGGACCGGCGGCGGGTGTTCAGCACGTACAGCTTCTCCAAGAGCTACGCGATGACCGGGTGCCGCCTCGGCTATGTCGTCACCCCCAACGATGTCACCGCGAGTGCGCTGCGGGTCGTCCAGGAGGCGAGCATCATCGCTCCGGCGACCCCGGTCCAGTACGCGGGCCTGGCCGCGCTGGACGCGCACAACGCGGTGCGGCGCCACCGTGAGATGGTCCGGGCGGCGCGGGACGAGGCACTGCCGATGCTGGTCACGGCGGGGCTGCTGAACGGGCTGCCGGCCGGCGGCTGGTACGCACTGCTCGACGTCGGACGCACCGGCATGGACGCGAACACCTTCGCCGAGGGGCTGCTCGCCGCGACGGATGTCGCGGTGGCACCCGCGACGGGGTTCGCCCTGCGGCCGGTCGTCGACGACACCGGCCGGGTGACCGAGATAGGGTCCCTGCCGATGGCGCGGCACTTGGTACGGGTGGCGATCTGCGGCGATCGCGAGCTGCTGTGCGCGGGCGTGCGGGCGCTGGTGGACTTCGCCGCGCAGCGGTAG	MAASAPASASAEFPPAAGIPPSCLHDVFRAADALERDTGRPVNQLHVGEPSFRMPPEVAEGLTKAITDGRTSYTSAEGMPQLREALTAKLETENGHHTTPDRVFVSPGSCQGLAALLQSIATPGAELLLPEVHWPIHLQQALLAGFRPVFYPLRADLGVDIERLAEVSGPRTRAIVVNTPSNPTGAVLEEAELRRLLALAEEHDWYVISDEAYEHFVYEGQHVSLASLERDLPPDRRRVFSTYSFSKSYAMTGCRLGYVVTPNDVTASALRVVQEASIIAPATPVQYAGLAALDAHNAVRRHREMVRAARDEALPMLVTAGLLNGLPAGGWYALLDVGRTGMDANTFAEGLLAATDVAVAPATGFALRPVVDDTGRVTEIGSLPMARHLVRVAICGDRELLCAGVRALVDFAAQR	MMKKSLCCALLLTAPLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAIAVIYQGKPYYFTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYRPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVNPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	108.92	gnl|BL_ORD_ID|2922|hsp_num:0	3937			549	711	
BGC0000434.1|SW-163_12 # 9377 # 10132 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.724	BGC0000434.1|SW-163_12 	9377	10132	-	Loose	700	25.409	ADC-17	41.18	3003861	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGAGTGTGTCCGGCAAGACTGTCGTGGTGACCGGCGCCGGCTCGGGCATCGGCCGTGCGGCGTGCGAGCTGTTGTGCCGGGCGGGCGCGCGGGTGGGGGCGATCGGCCGGCGCGAGAAGCTCCTGCACGCACTTCGCGACGAACTGCACGCCGAGCCAGGGGAGTTGGTGGCTCTGCCCGCCGACGTCGGCTCCGCGTCCGAGGTCGAGGCCGCGGTGCGGGCTCTGACCGAGCGCTGCGGCCCGGTGACCGGTGTCGTCAACAATGCCGGTCTGGCACGCTTCGCACCGATCGACTCAGCCTCGCTGTCCGACCTGGACGCCATGTTCGCGGTGCACCTCCGGGGCCCGGTGAACACGCTGCGGGCCTGCCTTCCCGCCCTGCGCGCACACCGTGGCGCGGTGGTGAACGTGTCGTCGGTCGGTGGCGCCCTGGCGATGCCGAACCGCTCCCTGTACGGCGCGACGAAGGCCGCCGTCAACAGCCTCACCCGCTCGTGGGCGCGGGAGCTGGCGCCCCGGATCCGGGTGAACGCGATCCTGCCCGGTCCGGTCGACACGCCGATGTACGCCGATCTGGGGCTCACCGACACGCAGACGGAGACGCTGCGCGCGGACCTGCTCGCGTCGACCCCGCTGGGCAGGTTCGGCGAACCCCACGAGGTCGCGAGGTGGATCGCGCTGCTGCTCGACGACGACATGTCGGGGTGGATCACCGGCGCGCTCGTACCGGTCGACGGCGGCAGAACGACGTGA	MSVSGKTVVVTGAGSGIGRAACELLCRAGARVGAIGRREKLLHALRDELHAEPGELVALPADVGSASEVEAAVRALTERCGPVTGVVNNAGLARFAPIDSASLSDLDAMFAVHLRGPVNTLRACLPALRAHRGAVVNVSSVGGALAMPNRSLYGATKAAVNSLTRSWARELAPRIRVNAILPGPVDTPMYADLGLTDTQTETLRADLLASTPLGRFGEPHEVARWIALLLDDDMSGWITGALVPVDGGRTT	MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDRQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNRENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	65.54	gnl|BL_ORD_ID|2438|hsp_num:0	2347			648	738	
BGC0000434.1|SW-163_13 # 10191 # 10973 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000434.1|SW-163_13 	10191	10973	-	Loose	290	38.5058	golS	43.9	3000504	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGACATCTGCGCCCGGTCGACCTCGCGCGTGAGCACGGCATCTCCACCCAAGCGGTCCGCAACTACGAGAAGGACGGCTGCGTCCCCCCGGCCGACCGCACCGCGAGCGGTTACCGCACCTACACCGCTGCGCACGCGGCGGCTCTGCGCGCCTATCTGGCGCTCATCCCGGCCCAGGGGTACGCGGTGAGCGGGCAGATCATGCGGGCGCTGAACACGGGCCGGATCGACGCGGCGCTGACGGCCATCGACCGCGGCCACGCCCAGCTGCTGCGTGACCGGGGCACGCTCGACGCGGTCGAGGAAGCGCTCCAGGATCTCGCACCCGCCGAGGGCACCGCCCTTCAACCCCCCACCGGCGGCGCCGCGTTCAGCATCGGGGAGCTCGCCCGCCGCCTCGGCGTCACCCCGGCGACCCTGCGGAACTGGGAGCAGGCGGGCATCCTCACCCCACGGCGCGAACCCGTCTCCGGACGTCGCTCGTACGGCCCCGACGACCTGCGTGACGCGGAGCTGACGCTCCTGCTGCGGCGCGGCGGGCACGGGCTCGACCACATCCGCACCATCATCGAGCAGATCCGGACGGCCGGGGGTACCCAGGCCCTCTACGCCGCCCTGCACGACTGGCGGCAGGGCCTCACCACGCGCGGACTCGCCATGCTGAGCGCGTCCGTACTGGTCGCGCGGTATGTCGAGCTGCTGGACGTCGGTACGAAGGTCGGTACGAAGGATTTCCGAAAGGCACGTCGAGGTACCGACGCTTCTGGGACAGAGTCGTAG	MRHLRPVDLAREHGISTQAVRNYEKDGCVPPADRTASGYRTYTAAHAAALRAYLALIPAQGYAVSGQIMRALNTGRIDAALTAIDRGHAQLLRDRGTLDAVEEALQDLAPAEGTALQPPTGGAAFSIGELARRLGVTPATLRNWEQAGILTPRREPVSGRRSYGPDDLRDAELTLLLRRGGHGLDHIRTIIEQIRTAGGTQALYAALHDWRQGLTTRGLAMLSASVLVARYVELLDVGTKVGTKDFRKARRGTDASGTES	MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSVAEISDLLNLWNNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDCPILHTLGQPDDSEPEARTGAVLRRPRRHGLAKRL	168.83	gnl|BL_ORD_ID|35|hsp_num:0	44			18	141	chloramphenicol
BGC0000434.1|SW-163_14 # 11149 # 12138 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000434.1|SW-163_14 	11149	12138	+	Loose	650	327.791	tetA(58)	50.77	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGACAGCCATCGAAGTGGCTGGACTATGCAAGAGCTTCGGCTCGGTGACCGCACTCGATCACCTCGAACTCACCGTGCCGGAAGGGACGGTGCACGGCCTGCTGGGTCCCAACGGCGCGGGCAAGACCACCATCGTCCGCGTCCTGAGCACCCTGCTCACGCCGGACGACGGAAGGGCCGAGGTATTCGGCGTCGACGTGCGCAGAGATCCACGACAGGTGCGCCGCATCATCGGCCTGACCGGACAGTACGCCGCGGTCGACGAATTGCTGACCGGGCGCGAGAACCTGGTCATGATCGGCCGGTTGTTCCGGCTGTCCAGGCCGGCCGCGAAGACCCGCGCCGGCGAACTGCTGGAGCGCTTCGACCTCGGTGACGCGGCCGACCGGCCGGCGCGGACGTACTCGGGCGGCATGCGGCGCAGGCTCGACGTCGCCGCGAGCCTCATGGCCCGGCCCCGGCTCATCTTCCTCGACGAGCCGACCACCGGGCTCGACCCGCGCAGCCGGATGGAACTCTGGCGGATCGTCCGTGAGCTGGTCGCGGAGGGCACCACCGTGCTGCTCACGACGCAGTACCTGGAAGAGGCCGACCAGCTCGCCCACTCGCTGTCGGTGGTCGACCATGGCAAGGTCATCGCCAGCGGCACCCCGGACCAGCTGAAGTCGCAGGTGGGCAACGACTGGGCGGTGGTGACCCTGATCGACACCGCCGACTTCGACACGACCACCGAACTCCTGCGGGACCAGCTGGGCGCCGGTCTGGCCGCCGACCCGGAGACGCTGCGGGTGCAGGCGCCATTGTCCGACGGCGGTTCGCTGGCCGATCTGCTGCACACGCTCCGGGAGTCCGGCGTCCAGATCGGCGATGTGTCCGTACGCCGTCCGACGCTCGACGATGTGTTCCTCGCGGTGACCGGACACGCCGCGCATTCCGCTGATCGGGAGACCGACGAGAAGACCGGGAAGGACACCACGTGGTCATGA	MPTAIEVAGLCKSFGSVTALDHLELTVPEGTVHGLLGPNGAGKTTIVRVLSTLLTPDDGRAEVFGVDVRRDPRQVRRIIGLTGQYAAVDELLTGRENLVMIGRLFRLSRPAAKTRAGELLERFDLGDAADRPARTYSGGMRRRLDVAASLMARPRLIFLDEPTTGLDPRSRMELWRIVRELVAEGTTVLLTTQYLEEADQLAHSLSVVDHGKVIASGTPDQLKSQVGNDWAVVTLIDTADFDTTTELLRDQLGAGLAADPETLRVQAPLSDGGSLADLLHTLRESGVQIGDVSVRRPTLDDVFLAVTGHAAHSADRETDEKTGKDTTWS	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	95.92	gnl|BL_ORD_ID|2243|hsp_num:0	2517			48	1017	tetracycline
BGC0000434.1|SW-163_15 # 12135 # 12959 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000434.1|SW-163_15 	12135	12959	+	Loose	500	136.732	tetB(58)	34.68	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGTCCGCGGCCTTGACGCCCGAAAGCAGCGCGGTGGAAGCGCGGCCGCAGGGCGGGGTCTCCTGGTGGTTCTCCGACCTGTGGGAAATGACGCTGCGCAACATCAGATATCTGGTGCGCAGCCCCGAGATGGTGCTGTACTCGCTCCTTCAGCCGGTGCTGTTCATTCTGCTGTTCGCGTATGTCTTCGGCGGCGCGATCGAGGTCGGCGGGGATTATGTGCAGTTCCTGCTGCCCGGCATTTTTGTCCAGATGGCGCTCTACGGATCGGCCACCGGCACCACCATCGGCGTCGCCGCGGAAATGCGCACGGGGCTGATGGACCGCTTCCGGTCGATGCCGATGAGCCGCACCGCCGTACTCCTCGGCCGTACGGTGTCGGAGGTCTTCCGCACCGTGGCCTCGCTGGCCGTGATGGTGCCCATCGGTCTGCTCATGGGCTTCCGCTTCGAGAACGGCTTCCTGCCCGCACTGGGCGGCATGCTGCTGTTGCTGCTGTTCGGCCACGCGGTGTCATGGCTCGGCGCCTGGATCGGTCTGTCGGTGCACAGCGCGCAGGCCGCCCAGGCGGCGGGCGGCGTGTGGGTCTTCCCGTTCGTGCTGATCTCCTCGGCGTTCGTGCCGACCGAGACGATGCCGGGATGGCTCCAGGTGTACGCGGCCAACAGCCCCATGACCACGGCCGTGAACGCGCTGCGCGCGCTGTTCACCGGCGGGCCCGCGGCGAGCGATGTGCTTCAGACGGTCGCCTGGTCCCTCGGTCTGATGGTGGTCTTCGGCTGGCTGTCGATGCGCAAGTTCGAGTCGCTGACGGCGCGTTGA	MTSAALTPESSAVEARPQGGVSWWFSDLWEMTLRNIRYLVRSPEMVLYSLLQPVLFILLFAYVFGGAIEVGGDYVQFLLPGIFVQMALYGSATGTTIGVAAEMRTGLMDRFRSMPMSRTAVLLGRTVSEVFRTVASLAVMVPIGLLMGFRFENGFLPALGGMLLLLLFGHAVSWLGAWIGLSVHSAQAAQAAGGVWVFPFVLISSAFVPTETMPGWLQVYAANSPMTTAVNALRALFTGGPAASDVLQTVAWSLGLMVVFGWLSMRKFESLTAR	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	101.11	gnl|BL_ORD_ID|4708|hsp_num:0	2518			87	795	tetracycline
BGC0000434.1|SW-163_16 # 13002 # 14171 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=CCA;rbs_spacer=15bp;gc_cont=0.717	BGC0000434.1|SW-163_16 	13002	14171	-	Loose	275	28.1054	AAC(6')-32	29.46	3002586	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGACCCGCCTCGACTCGGTGGACCTGGCCGGATTCCGGGTCAGGGACGGGGAGAAGTGGGGCAGCGTGGCGGACGGAGTGCTGCCCGCGTGGATCGCCGATATGGACTTCCCGGTGGCCCCCGCCGTGCGGGAGGCCTTGCTGCACCGCGTGGACACCGATCTGGGCTATCCGTCGGGGTACGACGAGTCCGACGGCGGCCCGCTGGGGCGCACCTTCGCCGACCGTATGCGGCGCCGCTTCGGGTTCGCCGCCGATCCGACGCATGTGCGCACCTTCACCGACATCAATCAGGCGATGCAGGTCGCGCTGCATCTGGGCACGGAGACCGGTGACCCGGTGGTGCTGCACTCCCCTGCCTGCCCGCCCTTCACCGACGTCCTGGTCAAGCTGGGGCGCCCGCCGCGACCGGTGCCGGTCGTGCACCGCGACGGGGACTGGCAGCTGGACCTGGACCGGGTGGCCGACGAGGTGCGGGCCGGGGCCCGCGCGCTGTTCCTGGTCAACCCGCACAATCCGACCGGACGGGTGTTCCGCCGTGCCGAGCTGGAGGCGCTGGCCGAACTGGCAGTCGCACACGACCTGTTGGTGATTTCCGACGAGGTCCACGCCGACCTGGTCTTCGACGGCCACCGGCACATCCCGTTCGCCTCGCTCTCCGCGGACGCCGCCGCGCACACCGTCACCCTCACCTCGGGAAGCAAGGCGTTCAACCTCGGCGGAGCACGCTGCGCCGTGGCCCATATCGGGGTGCCGCGGCTCCGCGAGGCCGTCGACGCCCATCGCGGCATCCTGTTCGGCCAGGTCGGGATCCTGGCCATGACGGCGCTGAAGGCGGCGTGGACCTCCGGCGACGGCTGGCTGGACGGTGTCCGCGAGGTGATCGCGCGCAATCGGCTGCGGGTGCACCAGGAACTGCCCGAGGGCGTGGTGCACCACCTGCCGGAGGCCACCTTCCTGTCCTGGCTGGACTGCCGTCCGCTCGGCCTGGGTCACGACCCGGCGAGCTTCTTCACCGAGCACGCCCGGGTGATGCTCTTCCGCGGCGGCGACTTCGGCCCCGAGGGGCTCGGCCACGTACGGCTCAACTTCGCCACGACGCCGGACATCCTCGACGAGGTGCTGCGCCGGATGCGGGAGGCGGTGGCACGGGTGCTGTCCGAGCGCTGA	MTRLDSVDLAGFRVRDGEKWGSVADGVLPAWIADMDFPVAPAVREALLHRVDTDLGYPSGYDESDGGPLGRTFADRMRRRFGFAADPTHVRTFTDINQAMQVALHLGTETGDPVVLHSPACPPFTDVLVKLGRPPRPVPVVHRDGDWQLDLDRVADEVRAGARALFLVNPHNPTGRVFRRAELEALAELAVAHDLLVISDEVHADLVFDGHRHIPFASLSADAAAHTVTLTSGSKAFNLGGARCAVAHIGVPRLREAVDAHRGILFGQVGILAMTALKAAWTSGDGWLDGVREVIARNRLRVHQELPEGVVHHLPEATFLSWLDCRPLGLGHDPASFFTEHARVMLFRGGDFGPEGLGHVRLNFATTPDILDEVLRRMREAVARVLSER	MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAVTPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQALVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERVRSAA	211.41	gnl|BL_ORD_ID|1443|hsp_num:0	1577			246	546	amikacin; tobramycin; gentamicin
BGC0000434.1|SW-163_18 # 16431 # 17117 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.677	BGC0000434.1|SW-163_18 	16431	17117	+	Loose	500	25.0238	blaC	42.42	3007182	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam; penem	antibiotic inactivation	class A Mycobacterium tuberculosis bla beta-lactamase	ATGACTTCATCCGACCTCTTCGAGTCCGTCTATCGCGGTGAAAGCGTGTACGGCAAACGCCCGCCATGGGAGATCGAGAGGCCGCAGCCCGCCTTCGTCGCGATCGAGGAGGCGGGACTCGTCAAAGGTGACGTCTTCGATCCGGGCTGCGGCACCGGCGAGACTTCGCTCTATCTGGCGAGCAAGGGCCACACGGTGACCGGCGTCGACTTCTCGGCGACGGCGATCGCCACGGCACGGCGCAAGGCCGAGGAGCGCGGTCTCGACGTCACGTTCGAGGTCGCCGACATCCTCGAGGACGGGGGCAAGAGCGGGCTCTACGACACCGTGATCGACTCCGGTACGGCGCGCATGTTCGACTCCGAGACGCTGGCGACCTACGCGGCGGCGCTGCACCGGCTGTGCCGGCCCGGGGCGTACGCGTACGTCCTCGCCCTCACCCAGAGCGGGATGGAGGACCTGACGGCGCGGCTCGCCGAGGAGATCGACGGCATTCCCAAGGAGGTCCCCAAGGACGACGAGGGCACCGGCGGACTGAGCCTGACGTTCCAGCACATCCCGGACGGCTTCTCCCGGCACTGGACGGTCGAGTCCGTCACCGACAGCGCGGTGCACTACATCCTCCCGTCCGAGACGACGGAGACCCTTCAACCGGCCTCCTGGCTCTACCGGTTCCGCCGAATCTGA	MTSSDLFESVYRGESVYGKRPPWEIERPQPAFVAIEEAGLVKGDVFDPGCGTGETSLYLASKGHTVTGVDFSATAIATARRKAEERGLDVTFEVADILEDGGKSGLYDTVIDSGTARMFDSETLATYAAALHRLCRPGAYAYVLALTQSGMEDLTARLAEEIDGIPKEVPKDDEGTGGLSLTFQHIPDGFSRHWTVESVTDSAVHYILPSETTETLQPASWLYRFRRI	MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLGVYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPVAQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDAEEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAGFPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAATCVAGVLA	74.27	gnl|BL_ORD_ID|4814|hsp_num:0	5800			438	537	cefoxitin; amoxicillin; cefalotin; temocillin; ticarcillin
BGC0000434.1|SW-163_19 # 17213 # 19198 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.673	BGC0000434.1|SW-163_19 	17213	19198	+	Loose	150	28.4906	nimK	34.15	3007113	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	ATGCCCCTGGAGTCGATGCCTTTGGCGTCGGGATATCTGAAGGCCTGCGTCCAGACCGACGAGCGTGTCCGCGACCGCGTGGATGTGTCGATCCGCAACTTCCGCGGCGGCGTCACCCTGATGCGGATGGCGAACGAACTGTTCGCCGAGGGGGCGCCGGACGTGCTGGCGTTCTCGGTGCTCGGCTGGAACATCCGTGAGTTCGGGGCGCTGGCGGAGACGTTCAAGCAGCTCAACCCGCGCGGTCTGGTGGTGTTCGGCGGCACGCATGTGGCGAACCAGGCGGAGCGCACGTTCCGGATGTTCGACGACGTCGACGTCATCGTAAACGGCGAGGGCGATTTGGTGCTGCCCGATGTGCTGGACGCGTATCTGCGCGGGGTGGAACGCACCGCGCTCGGGGACATCGCCGGCATCACCTACAGGGACGCCGGAGGCACCGTGGTGACGACCCCGCCACGGCCCCGGATTCAGGACCTGGACGTGATTCCGTCGCCGTTCCTGACCGGAGCGATCCCGCTGCTCGACGACAACGACCGGTTCCGCTACGACGTCGCGCTGATGGAGACCAACCGCGGCTGCCCGTACAAGTGCTCGTTCTGCTACTGGGGCGGTGCCGTCGGGCAGCGGGTGCAGAGCTTCTCGCGGGCCCGGCTGCGGGCGGAGCTGGAGCTGTTCGCCCGGCTCAAGGTGCACACCATCGTGCTCTGCGACGCGAACTTCGGGATGCTGCGGGCCGACGAGGAGTTCGTCGACGATGTGATCGACCTCCGCGAGCGGTACGGGTATCCGCGCGCCGTCGAGGCCTCGTGGGCGAAGAACAAGTCGAAGGTGTTCTTCAACATCGTGCGGAAGATGAAGAAGCACGGCATGCGCAGCTCCTTCACCCTGGCCCTCCAGACGCTCGACGACACCGCGCTGCACCTGATGAACCGCAAGAACATGAAGGTGAACGACTGGGAGGACCTGGCCGCCTGGCTGAACCGGGAGGGCCTCGACGCCTACGCGGAGCTGATCTGGGGTGCCCCGGGGGAAACGGTCGAATCCTTCCTGGAGGGCTACGACCGGCTGTCCCGGCATGTCTCACGGATCGCCGTGTATCCGCTGCATCTGCTGCCCAACACGGACTACGCGGAGAAGAAGGCGGAGTACGGCATCGTGTCCGTGCGCGGCAACGTCGATGACTTCGAGTACATCCTGTCCCACAACACGATGAGCTTCGCCGACAACCGGCGGATGAAGCGGTTCCTGTTCTGGGCGCGGGTGATGGCGGAGAACGCCGTTCTGCGCGGTACCTGGGTCGCCATCCGCGATCTGAGCGACCTCACCCAGTCCCAGGTGCTGACCAAACTCGACGCGTTCGTGCACCGGGTCGACGATCCGGCGGCGCAGCCGCTGCGGGCCTGGGTCGCGGAGGCGGAGAACAGCAACACCGCCTGCGGAGACGCCATCAAGTACCTCTTCGGCGACCCGGTGGCACGGCAACTGCTGAAACGCTGGTGGACGGAGTCGGTGCGTCCGCTGCTGCCTCCGGAGCGGGGGGACCTCTTCGACGAGGTCTTCCGGTACGACCTGCTCACCCAGCCGTACTACCACCACCCCGACGCCGCGGGCCGGCCCGAGCGCCTGGACACCGAGACCATCCGTGGCGAGCGGTATCTGCGGCGCAGCGGTGTGACGATGCGTTACGACGTGCCGGCGCTGCTTGTCGCGCTGCGGACGGGGCAGGTCACACCGGCGGAGCTGACGGCCCGTGAGCACACCGTGGACCTCTTCTACCGCCAGGGCGCGGAGAACTTCATCGGGTCCACGAACCATGAGGAGGTCGTCCACTTCGTCGGGCTGACCCGGGACGAGGTGGAGGCGGCCGCCGCCGTCCGCGCGGCGAAACGCGACGCGGAGGACACCGACGAGGACGCCCAGCAGGTGCAGGGCGGTCGGCAGGGCCTGTCCCTCACGCTCAGTGAGCACGGCGGCTATTCGTGA	MPLESMPLASGYLKACVQTDERVRDRVDVSIRNFRGGVTLMRMANELFAEGAPDVLAFSVLGWNIREFGALAETFKQLNPRGLVVFGGTHVANQAERTFRMFDDVDVIVNGEGDLVLPDVLDAYLRGVERTALGDIAGITYRDAGGTVVTTPPRPRIQDLDVIPSPFLTGAIPLLDDNDRFRYDVALMETNRGCPYKCSFCYWGGAVGQRVQSFSRARLRAELELFARLKVHTIVLCDANFGMLRADEEFVDDVIDLRERYGYPRAVEASWAKNKSKVFFNIVRKMKKHGMRSSFTLALQTLDDTALHLMNRKNMKVNDWEDLAAWLNREGLDAYAELIWGAPGETVESFLEGYDRLSRHVSRIAVYPLHLLPNTDYAEKKAEYGIVSVRGNVDDFEYILSHNTMSFADNRRMKRFLFWARVMAENAVLRGTWVAIRDLSDLTQSQVLTKLDAFVHRVDDPAAQPLRAWVAEAENSNTACGDAIKYLFGDPVARQLLKRWWTESVRPLLPPERGDLFDEVFRYDLLTQPYYHHPDAAGRPERLDTETIRGERYLRRSGVTMRYDVPALLVALRTGQVTPAELTAREHTVDLFYRQGAENFIGSTNHEEVVHFVGLTRDEVEAAAAVRAAKRDAEDTDEDAQQVQGGRQGLSLTLSEHGGYS	MFREMRRKRQQLSTEECIAILEKMTSGVLALNEEGGYPYAVPLSYVYSDNKIYFHSAIKGHKIELLEKNENVSFCVIFQDHIVPEEFTTYFQSVIVFGKARILLDEKEKMSALWKLGEKYSSGNAEALSAEISKGKNHLLIIEIAIEHMTGKESIELVRAKKSIKESK	393.45	gnl|BL_ORD_ID|4790|hsp_num:0	5786			63	186	metronidazole
BGC0000434.1|SW-163_21 # 20001 # 21803 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000434.1|SW-163_21 	20001	21803	-	Loose	1000	129.413	almE	26.05	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACACGTGACGTCGACGGGCACGGCGCGGCGCACGGCCGCGCGCCGGACGTGGTGCCGCGCACCGTACCGCGTCTGTTCGAGACGGTCGCCGCGCGGGCGGGCGACCGGACCGCCGTGCTGTTCGAGGACACGGCGGTCAGCTACGCGGAGCTGAACACGGCGGCCAACCGGCTCGCCCGGTGGCTGATCGACCGCGGGGTGGGCCCCGACCGCGCGGTCGCGGTCTCCGCGCCCAAGTCCGAGGACCTGATCACCGTGCTCCTGGCGGTGCTCAAGGCGGGCGGCGCCTACCTCGCGCTCGACCCGGCCTATCCGTCCGAACGGCTTGCGCACATGGTGGCGCAGGTCCGGCCGGTGCTGCTGCTCCACACGGCCAAGGACGCGGAACTCGCCACGCCTGGCACCGACATGCCGCGCATCGTCATCAACGACCCCGACGTCCGGGCCGAGTGGGAGGCGCGTCCCGGCCACGACGTGACCGACGCCGAGCGGCGCGCGCCGCTGCGCCCCGACCACCTGATGTACATCGTGTTCACCTCGGGGTCGACCGGCAGACCCAAGGGCGTCGCGGTGACGCACGGCGGCGTCGCGGGCCTGGTGGCCGGTCAGCGCGAGCAGATCGGCACGGGCCCCGGCGACCGCGTGCTCCAGTGGGCGTCGATCAGCTTCGACGCCGCCTTCTGGGACATCTCACTCGCGCTGCTGAACGGCGCGACCCTGGTGATGGCCGGGGCCGACGACCTGCTTCCCGGCCAGCCGCTGCGGGACACACTGATCGACCGGCGGGTGACCCATGCCACCCTGCCGCCGGTCGCCCTGAGCGTCACCGACGCCGACGATGTCCTGCCGGGCGGCACGCTGGTGTCGACCGGCGACGCGGTGTCCCCCTCCCTGGTGCGCACCTGGGCCGAGGGCCGGAGGATGTTCAACGGCTACGGCCCCACAGAAGTGACCGTCGGCAGCAGCATCGGGCGGATCTCGGACCCCGACGACATCGGCATCGGCCGGCCGTTCCCCGGCAGCGCGGTGCGCGTCCTCGACGAGCGGCTGTCCCCCGTCGGCGGCGGGGAGGAGGGCGAACTGTATCTGGCGGGCCCTGGCCTGGCGCGCGGATATCTGAACCACCCCGGGCTGACCGCGACACGGTTCGTGGCCGACCCGGCGGGGCCGCCCGGCAGCCGGATGTACCGTTCGGGCGACCGGGGGCGGTGCCGCGCGGACGGCGAGCTGTTTTTCACCGGCCGGGTGGACAGCCAGGTCAAGGTCCGCGGCTTCCGGATCGAACTGGGCGAGATCGAGGCTCGGCTGGCCGCGCACCCGGCCGTGGACCTGGCCTGTGTCGTGGTGGAGGGCGATATCGCGACCGCCCGGGTCATGGGGTACGTGACCACATCCACCGGCGCCGGTGCCGACGGTGCGGAGCTGCGGCGGTACGTGGCCAGGTCGCTGCCCGAGCACATGGTGCCGTCCACCGTGGTGGTCCTGGACCGCTTCCCCACCGACCCGAACGGCAAGGTCGACCGGGCGGCCCTCACCGCCGCCCGCGCCGGGCGCCCGGCGGCGGAGGCGGCCGCCTCCGGGGACATCGACCTGTGCGAGCTCGTCCGGCGGATCCTCGGGGTCCCGCGGGTACGGCCGCAGGACAACTTCTTCGAGCTGGGCGGCCACTCGGTGCTGGCGACGATGCTGGCACGCCAGATCCGCAAGGAATTCGACGTCGTGATCCCGATGCGGAGCATATTCGAGGCCGCGACACTGGCCGAACTGGCGGACCTGGTGGACGCGGCCCGGCAGGAGTGA	MTRDVDGHGAAHGRAPDVVPRTVPRLFETVAARAGDRTAVLFEDTAVSYAELNTAANRLARWLIDRGVGPDRAVAVSAPKSEDLITVLLAVLKAGGAYLALDPAYPSERLAHMVAQVRPVLLLHTAKDAELATPGTDMPRIVINDPDVRAEWEARPGHDVTDAERRAPLRPDHLMYIVFTSGSTGRPKGVAVTHGGVAGLVAGQREQIGTGPGDRVLQWASISFDAAFWDISLALLNGATLVMAGADDLLPGQPLRDTLIDRRVTHATLPPVALSVTDADDVLPGGTLVSTGDAVSPSLVRTWAEGRRMFNGYGPTEVTVGSSIGRISDPDDIGIGRPFPGSAVRVLDERLSPVGGGEEGELYLAGPGLARGYLNHPGLTATRFVADPAGPPGSRMYRSGDRGRCRADGELFFTGRVDSQVKVRGFRIELGEIEARLAAHPAVDLACVVVEGDIATARVMGYVTTSTGAGADGAELRRYVARSLPEHMVPSTVVVLDRFPTDPNGKVDRAALTAARAGRPAAEAAASGDIDLCELVRRILGVPRVRPQDNFFELGGHSVLATMLARQIRKEFDVVIPMRSIFEAATLAELADLVDAARQE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.91	gnl|BL_ORD_ID|4935|hsp_num:0	5928			36	1650	colistin A; colistin B
BGC0000434.1|SW-163_22 # 21867 # 23330 # -1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000434.1|SW-163_22 	21867	23330	-	Loose	1000	67.0106	almE	24.11	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGGCCGTCGTCTGCGACGAGGAGCGGCTGACCTACGCGGAGCTGGCCCGGCGGGCCGACCGGCTGGCGCGCGGACTGCTCGGGGCGGGACTGAAACCGCTCGACCGGGTGGTCGTGCAACTGCCCAACGTCCCCGCGTTCCCCGTCGTGCTCTTCGCGCTGCTGCGCGCCGGGGTGATCCCGGTCCTGGCCCTCCCCGGGCACCGCGCGCTGGAGATCGCCCACCTGAGCGAGCACTCCGGTGCCGTGGCCTACATCGTGCGGGACGAGTTCGGCGGATTCGACTACCGGCAGCTGGCACGGGAGATCCCGTCGGTCCCGCGGGTGCTCGTCAGCGGTGACGCCCAGGAGTTCACCGACCTGGACTCGCTGCGCGGCGACGACATCGCCCTGCCCGCGGTGGACCCGGCCGCCCCCGCGCTGTTCCTGCTGTCGGGCGGCACCACCGGACAGCCGAAGCTGATACCCCGCACCCATGACGACTACGGCCTCGTCGTACGGGCCTGCTCCGAAGCGGTGGGCGCCGACCGGGACTTCACCTACCTCGCCGTCAACCCGGCCGCGCACAACGCGGCGTTGGGGTGCCCCGGCATCCTGGGCGCGCTGCTGCTCGGCGGCAAGGCGGTACTGACCTCGACGGTGCGGCCCGACACGGTGTTCCCGCTGGTCCGCCGGGAGGGGGTCACCCTGACCACGGTCGTCCCCGCCGTGCTGCGGCTGTGGGCCGACGCGGACCGGGACACCGGCGACCTGGCGGGGCTGACGCTCCAGGTCGGCAGCGCCCCGCTGGACCCGGCGCTCGCACAGCGGGCGGGCAAGGCGCTGGGCCGCGAGGTGATGCGCTGGTACGGCATCAGCGAGGGGATGCTGACGCACACCAGGTCCGACGACCCGGACGAGGTGAAGACGGGCACCGACGGGCGGCCCATGTGCCCGGAGGACGAGGTGCGCGTCGTCGACACGTCCGGGGCGGTGGTGCCCGACGGCGAGACCGGGGAGCTGCTGACCCGGGGCCCGTACACGATCCGCGGATACTTCCGGGCTCCCGAGGAGAACGCGCGCTCGTTCACACCCGACGGGTTCTTCCGCACGGGCGATCTGGTGCGGCGCTCGGCCGACGGCAACATCGTCGTGGTCGGGCGGGTCAAGGAGATCATCAACCGCGGCGGCGAGAAGGTGTCCGCCCTGGAGGTGGAACGCCAGCTCTGCACCCACCCGGAGGTGCGGGACGCCGCGGTCATCGGCGTGCCGGACGCCTCCCTGGGCGAGCGGACGTACGCGTTCGTGGTGGTCGCCGGGGACGGCTTCCGGGCGGCCGCCATGAAGGAGTTCCTCCGGGGGTGCGGGCTGGCCACGTACAAGATCCCCGACCGGATGGTGCGGCTCGACGAGCTGCCTCGCTCCCCGATGGGCAAGGTCGACAAGAAGGCCCTGCTGTCTCTCGCCACACCACCCGCGAGGTGA	MAVVCDEERLTYAELARRADRLARGLLGAGLKPLDRVVVQLPNVPAFPVVLFALLRAGVIPVLALPGHRALEIAHLSEHSGAVAYIVRDEFGGFDYRQLAREIPSVPRVLVSGDAQEFTDLDSLRGDDIALPAVDPAAPALFLLSGGTTGQPKLIPRTHDDYGLVVRACSEAVGADRDFTYLAVNPAAHNAALGCPGILGALLLGGKAVLTSTVRPDTVFPLVRREGVTLTTVVPAVLRLWADADRDTGDLAGLTLQVGSAPLDPALAQRAGKALGREVMRWYGISEGMLTHTRSDDPDEVKTGTDGRPMCPEDEVRVVDTSGAVVPDGETGELLTRGPYTIRGYFRAPEENARSFTPDGFFRTGDLVRRSADGNIVVVGRVKEIINRGGEKVSALEVERQLCTHPEVRDAAVIGVPDASLGERTYAFVVVAGDGFRAAAMKEFLRGCGLATYKIPDRMVRLDELPRSPMGKVDKKALLSLATPPAR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	87.59	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0000434.1|SW-163_24 # 24829 # 25575 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000434.1|SW-163_24 	24829	25575	+	Loose	450	28.1054	BlaB-12	29.23	3005525	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGAGCCGGATGCGGGAACAGGGCTGGATACGGTCACTGGCCACGGTCGAGGCTCCCGCCGTCCGGCTGGTGTGCTTTCCGCACTCCGGGGGCTCGGCGTCGGCGTTCGCCGACTGGGCCACCGCGCTGCCGCCCGAGGTGGAACTCGTGGCCGTTCAGTACCCCGGCCGCGGTGACCGCTTCGTCGAGCAACTCGTCGACGACGTCGCCGAGATGGCCAGCCACGCCGTGGCCGAGCTGCTCCAGCTGCCCACCTGCGACGACGTGCTGTTCGGGCACAGCCTGGGCGCCCTGGTGGCCTACGAGTCCGCCCTGCTCCTGCGCGACATGGGCGAACAGCCGAGGATGCTGTGCGCCTCCGCCTGTCTTCCCCCGGGGCATATGAAGAACCGGGAGGTCCACGCGGCGCCCGACGACGAGTTCTGGGCGACCCTGTACGCGCTGGGCGGCATCGACCCCGGGATCGCCGAGAACGAGGAGCTGCGCGAGCTGCTGCTGCCGACGCTGCGCTCGGACCTGCGGGCGCATGCGACCTATCGGCCCTGCTCCGGGACCAAACCGCTGTCCTGCCCGGTGAGTTGCTACCACGGCATCGGTGACCCGATGGTGGACGAAGCGCTGCTGGGGGAGTGGGCGGACGTCACCTCGGGCGATTTCAGACTGCGGGTGCGGCCGGGCGGTCACTTCCACGTGGGCACCGACATCGCGGGTCTGGTGTCGGACGTCCTGGGGCGCGAAACGGCCTGA	MSRMREQGWIRSLATVEAPAVRLVCFPHSGGSASAFADWATALPPEVELVAVQYPGRGDRFVEQLVDDVAEMASHAVAELLQLPTCDDVLFGHSLGALVAYESALLLRDMGEQPRMLCASACLPPGHMKNREVHAAPDDEFWATLYALGGIDPGIAENEELRELLLPTLRSDLRAHATYRPCSGTKPLSCPVSCYHGIGDPMVDEALLGEWADVTSGDFRLRVRPGGHFHVGTDIAGLVSDVLGRETA	MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTSKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYSTKMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIIKSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISEYQQKQKASN	99.60	gnl|BL_ORD_ID|3304|hsp_num:0	4373			18	204	
BGC0000434.1|SW-163_25 # 25646 # 28024 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.683	BGC0000434.1|SW-163_25 	25646	28024	-	Loose	650	51.9878	tetA(58)	32.56	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGTGAGGACGACTGCCGACACTCAGCAGACCGAACAGGACTTAGCCGATCAGCACGACCGGATCCGCGTGCACGGCGCACGGGAGAACAACCTGCGGGACGTGAGTCTGGAGATCCCCAAGCGCCGTCTGACGGTGTTCACCGGTGTCTCCGGATCGGGCAAGAGTTCGCTGGTCTTCAACACGATCGCCGCCGAGTCGCAGCGGCTGATCAACGAGACCTACAGCGCCTTCGTGCAGGGGTTCATGCCGTCCATGGCGCGGCCCGAGGTCGAGATGCTGGACGGGCTGACCACCGCTATCATCGTCGACCAGCAGCCGCTGAGCGGCCATCCCCGCTCCACGGTCGGCACCGCCACCGATGCGGGCGCGCTGCTGCGGATCCTGTTCAGCCGCCTCGCCAAGCCGTACATCGGCACCCAGAAGGCGTTCGCCTTCAACGTCGCGTCGGCCGACGCGTCGGGCACCCTGGTGGTGGGCGGCAAGGCCATCGAGAAGCGCGTCAGCGTCGTCGGCGGCATGTGTCTGCGCTGCGAGGGGTTCGGCACGGTCACCGACATCGATCCGGACCAGCTGTACGACGCCGACACGTCGCTGGCCGACGGCGCGATCACGGTCCCCGGCTGGAAGCCCGACGGCTGGGTGGTGCAGTCGTTCATCCAGTCCGGCTTCCTCGACCCGGCCAAGCCGATCCGCGACTACACCGCCGCGGAGATGCACGACTTCCTGCACCGCGACCCGGTGAAGGTCAAGGTGAAGGGCGTCAACACCACCTACGAGGGCCTGCTCGCCCGGGTGCGGAAGACATTTCTGGCCAAGGACCAGGAGGCTCTTCAGCCGCATATCCGGGCCTTCGTGGATCGGGCGGTGACCTTCACCGCCTGCCCCGACTGCCAGGGCACCCGGCTCAGCGAACTGGCCCGGTCGGCGAAGATCGACGGGGTCGACATCGCCGAGGCCTGCGCGATGCAGATCACCGACCTGTCCGCGTGGGTGCGAAACATCGCCCAGCCGTCGATCGTCACCCTGGCGGCGAACCTGTGTCAGGCCCTCGACGCCTTCGACGACATCGGTCTTGGCTACCTCTCGCTGGACCGGCCCACCGGCACGCTGTCCGGCGGCGAGGCGCAGCGCGTCAAGATGGTCCGCCATCTCAGCTCGGCGCTCACCGACGTCACGTATGTCTTCGACGAGCCGACCGTCGGTCTGCACCCGCATGACATCCAGCGGATGAACAACCTGCTCAGGCGGCTGCGCAACAAGGGCAACACCGTGCTGGTGGTGGAGCACAAACCGAAGATGATCATGATTGCCGACCATGTCGTCGACATGGGGCCGAAGGCCGGCACCGAGGGCGGCCAGGTGGTCTTCGAAGGCACCATCGACGAACTCCGGTCCAGCGGGACGCTGACCGGCCGGCATCTGGATGCCGGTGTCCGACTCAAGCCGACGGTGCGCACCCCGACGGGCAAGCTCGCGGTGCGCGGCGCCAACGACCACAACCTGCGGAACGTCGATGTCGACATCCCGCTGGGCGTGCTCACCGTGCTCACCGGAGTGGCCGGTTCCGGAAAGAGCTCGCTCATCCGCGGCTCCGTGGCCGACCGGGAGGGGGTCGTGCTGGTGGATCAGGGCCCCATCAAGGGCTCCCGGCGCAGCAATCCGGCCACCTACACCGGGATGCTGGAGCCGATCCGCAAGACCTTCGCCAAGGCCAACGGCGTCAAGCCCGCCCTGTTCAGCCCCAACTCCGAGGGCGCGTGTCCGCAGTGCAAGGGCGCCGGGGTCGTCTACACCGACCTGGCGATCATGGCGGGCGTCGCCATCACCTGCGACGAGTGCGAGGGCAAGCGGTTCCAGCCGTCCGTCCTCGACTACCGCGTCGGCGGCCGCAACATCAGCGACGTCTTCGAGATGTCGGTGGCCGCGGCCGAGGAGTTCTTCGGCCAGGGTGAGGCGCGCACCCCCGCCGCGCACACCGCCCTGCGGCGGCTCGTGGACGTCGGGCTCGGCTACCTCCCGCTCGGCCAGCCGCTCACCACGCTGTCCGGAGGCGAGCGGCAGCGGCTGAAGCTGGCGGCGCACATGAATGAGGACCGCAGCGTCTTCGTGCTGGACGAGCCGACCTCCGGTATGCACCTCGCCGACGTGGAGCAGTTCCTCGCGCTGCTCGACCGGTTGGTGTCCGCGGGCAAGTCCGTCATCGTGATCGAGCACCACCAGGCCGTTATGGCACATGCCGACTGGATCATCGATCTGGGTCCCGGCGCGGGCCACGACGGCGGCCGGATCGTCTTCGAGGGGACACCGGCCGACCTCGTCGCCGCCCGCTCCACGCTGACGGGCGAGCATCTGGCGGATTACCTGGGCAGCTGA	MTVRTTADTQQTEQDLADQHDRIRVHGARENNLRDVSLEIPKRRLTVFTGVSGSGKSSLVFNTIAAESQRLINETYSAFVQGFMPSMARPEVEMLDGLTTAIIVDQQPLSGHPRSTVGTATDAGALLRILFSRLAKPYIGTQKAFAFNVASADASGTLVVGGKAIEKRVSVVGGMCLRCEGFGTVTDIDPDQLYDADTSLADGAITVPGWKPDGWVVQSFIQSGFLDPAKPIRDYTAAEMHDFLHRDPVKVKVKGVNTTYEGLLARVRKTFLAKDQEALQPHIRAFVDRAVTFTACPDCQGTRLSELARSAKIDGVDIAEACAMQITDLSAWVRNIAQPSIVTLAANLCQALDAFDDIGLGYLSLDRPTGTLSGGEAQRVKMVRHLSSALTDVTYVFDEPTVGLHPHDIQRMNNLLRRLRNKGNTVLVVEHKPKMIMIADHVVDMGPKAGTEGGQVVFEGTIDELRSSGTLTGRHLDAGVRLKPTVRTPTGKLAVRGANDHNLRNVDVDIPLGVLTVLTGVAGSGKSSLIRGSVADREGVVLVDQGPIKGSRRSNPATYTGMLEPIRKTFAKANGVKPALFSPNSEGACPQCKGAGVVYTDLAIMAGVAITCDECEGKRFQPSVLDYRVGGRNISDVFEMSVAAAEEFFGQGEARTPAAHTALRRLVDVGLGYLPLGQPLTTLSGGERQRLKLAAHMNEDRSVFVLDEPTSGMHLADVEQFLALLDRLVSAGKSVIVIEHHQAVMAHADWIIDLGPGAGHDGGRIVFEGTPADLVAARSTLTGEHLADYLGS	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	230.90	gnl|BL_ORD_ID|2243|hsp_num:0	2517			381	738	tetracycline
BGC0000434.1|SW-163_27 # 28306 # 36030 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000434.1|SW-163_27 	28306	36030	+	Loose	1000	138.658	almE	30.71	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTGGCTCGCACAGAAGTTCGCCCCGGCCCAACCGAACAATGTGGTGACGCTGTGGAACGTCGACGGTGGCCTGGACGTCCCCCTCTTCACCTCCGCGCTGCACATGGTGATGGCGGAGACCGACCCTCTGTGGGTGAATTTCCGGCGAGGTGCTGACGGGCTCCGGGTGATCGCCCGTGACCCGGGGACGTGGGCACCGTTTCACCTCGACGTCCAAGACGCCCCCGACCCGGATGACGCGGCCCGTGCCGCCGTCGCCTCGCTGACGAGCGAACCGTTCGACCTGGCGCGGGACGCGCTGCTGCGGGTCGGCTCCATCCGCCTGGGCCCGGACCGTCACCTGGTGGTCCTGATCTTCCATCACATCCTCACCGACGCGTTCGGTGTGCTCATGCTGCTGTCCCGGCGGATCGCCGAGGTCTACCGGGCGCTGTACGAGAAGTCCGACGTCCCCGGATGCGTCGCGCGGCCGGCGGGCGACGCCGCCGCGGCGGACGCCGCGTACCGGACGTCGCGCCGGTTCGCCGACGCCGAGCGGTTCTGGCGCGACTACCTCGCCGGTGAGCCGACCGCGGCGCGGCTCCCCACCGGCGTACGCCCGCCCGAGGGGGCACCCCCGAGTGAGCGCGGGCCCTGGGACTTTCTCACCGGGCCGCTGGGCATGACCACCCGCACCGCGACGGTTCCGGCCGCCGAACGCGCCTCATGGGAAGGCGCGGCGCAGCGGCTGAAAACGAGCGTGCCGGACCTGCTCTCCGCCGCGGCCGCGGCCTACCTCCAGCTGATGTGCGGCCCGTCCGCCCCCCTGCACACCATCACCGTCAACCACCGCACCGGTGCCGCGCGGCAGGCGCTCGGCCTGTACTCCAACCGGATCCCGATCCGGGCCGCGGCCGCCCCCGAAGCGAGCCTGGTGGAGCTGGCCGTGGCGCTCGGCCGGGAGCGCCGCGGTGTGCTGCGGCACGCCCGGCACGAACTGGCCCTGATCAAGCGGGCCACCGGGCACGCCGCCGAGGCGCGCAGCCCGTTCGGCACCATCGTCAACGTCTTCCCGTTCGTCGAGGCACTCGACCTCGCGGGCAGCGTGGCGCGGTTCGCGGGCGGCACGTTCGGCCTGGTCGACGAGATCATGGTGTCCCTCTACACCGATGGCACCGCCGACAGCGATCTGTACGTCCGCTTCGACGCACCCGCCGCGCACTACGGCGAGCGGGACCTCGCCGGTCTGGCCGACAGCTTCGTGCCGTTCCTCCGCGCCGCGCTCGCCGACCCCGCGCGGCCGGTCGCGGACATCAGCCCGCTCGGCGCCGTCGAACAACGCGCGCTGCTCGCCGCCTGCTCCGGCCCGGCGGTCGACGTCCCGGACGTCACACTGACCGAACTGCTGGACCGGCAGGCCCGCGCCACCCCCGACGCGACCGCGGTCACCTTCGAGGACGCGGGCCTGACCTACCGGGAGCTGGCCGACCGGTCCGGCCGCCTCGCCCGCACCCTGATCGAGGCGGGCGCGGGCCCCGAGCGCTTCGTCGCGGTGGCCATCCCGCGCTCCCTGGACCTCGTCGTGGCGCTGATCGCGGTGCTCAAGGCGGGCGCGGCCTACGTCCCGGTCGACCCGGAATACCCCGCCGCCCGCGTGGAGTTCATGCTCGCCGACGCGCGCCCCGCGCTGCTCCTGGTGGCCGGGGAGAGCGCCGGGAAGCTGCCCGTCGGGGATGTCCCCGCCCTCGCCGTGGACGAGATCCCCCTGACCGGCGGGGCTACCGCGACAGCACCCCACCGCCCCGATCACCCGGCGTACATGATCTACACATCCGGGTCGACCGGGCGGCCCAAGGGCACGGTCATCACACACGCCGCGATCGTCAACCGGCTGCTGTGGATGCAGGACCACTTCCGGCTGGACGGCACCGACCGGGTGCTCCAGAAGACCTCGGCCTCCTTCGACGTATCGGTCTGGGAGTTCTTCTGGCCGCTGATCACCGGCGCCACCCTCGTGATGGCCCGGCCGGACGGCCACCGCGACCCCGCCTATCTCGCCGAGGTGATCGAGCGGGCCCGGGTCACCACGCTGCACTTCGTCCCGTCCATGCTCGTCGAGTTCACCGCCGAGGAGACCGCGGCCCGCTGCACCGGTCTGCGCCGGGTCGTGTGCAGCGGCGAGGCGCTGCCCGCCGACGTCGCCGCGCGGTTCGACCGGCTCTTCGGCGTGCCCCTGCACAACCTGTACGGGCCGACCGAGGCGGCGGTGGACGTCACCGCGTGGCGGTGCCGGCCGGAGGCCGCCACCATCCCCATCGGCACCCCGATCCAGAACACCACGCTGCTCGTGCTCGACAGCGGGCTCCGGCTGGTCCCCCGCGGCGTCCGCGGCGAGCTGTACATCGTGGGTGCCGGGCTCGCGCGGGGCTACCTCGGCCGCTCGGCCCTCACCGCGGAGCGGTTCGTCGCGTGCCCGTTCGGACCCGCCGGGCAGCGCATGTACCGGACCGGCGACCTGGCGCGCTGGAACGCCGACGGCGACCTCGAGTTCGCCGGACGCGCCGACCACCAGGTGAAGATCCGTGGCTTCCGGGTCGAGCCCGCGGAGGTGGAGGCGGTGCTCGCCGCCCACCCCGGGGTGGGCGGCGCCGCGGTCGTCGCCCGGGAGAGCCGCGGCGCCGACGGGGCCGCCCAACTGGTCGCGTACGTCGTGCCCAAGACTGTCGTCGGCACCGGCCGGCAGGCCACGGACTGGGACTTCCACGCCGGTCTCGACATCGCCGAGTTACGCGCCTTCACCGCCGCCCGGCTGCCGAACCACCTGGTCCCCGCCGCCTTCGAGATCCTGGACCGGCTGCCGCTGAGCGCCAACGGCAAGCTGGACCGCGGCGCGCTGCCCGAACCGGAGTTCGCCGCCCGCGCCTACCGGCCGCCCAGCAGCGACGAGGAGCGGCTGCTGGCGGACGCCTTCGCCCAGGTGCTCGGGGTGAGCCGGGTCGGGGCGGACGACGACTTCCTCGCCCTCGGCGGCGACAGCATCCGGGCCATCCAGGTGGTGGCCCGCGCGCGGGCGGGCGGCCTCGCCTTCACCCCGCGCACCGTGTTCGAGCGCCGCACCGTCGCGGCGCTGGCCGTCGCCGCGACGCGCGACACCGCGGCGCCGGTGCTCGCCGAACTCGACGGCGGCGGCGTCGGCCTGGTGCCGCTGCCGCCGATGGCGCGGCTGATCGCCGAGCGCGGCCCAGGACTCGACCGGCTCGCCCAGTGGCTGGTCCTCGAACTGCCCGCCGGGGTGGACCGCGATGGCCTCGCCGCGACGGTCGGCGCCGTCCTCGACCGGCACGACGTGCTGCGCTCGCGCCTCGTCGACGACGGCCTGTTGGTGCTGCCGCCCGGCGCGGTGGACCCCGCCGTACTGATCACCCGGGTCGGCTGTCCGGGCCACTGGGACGCCCCCTCCTGGCGTCAGCTGCTGCGCACCGAGGCCGACGCGGCGCTGCGCGCCATCGACGCCCGGGCGGGCCGCATGCTCCGGCTCGTGTGGTTCGACCCCGAGGCGGGCGGCCCCGGGCGGCTGCTGATAGCCGCGCACCACCTCGTGGTCGACGGCATGTCATGGCGGGTGCTGCTCCCCGACCTCGCCACGGCATGGCGGCACATACGGGCGGGCACGGCACCGGAACTGCCGCCGGTCGGCACCTCGCTGCGGCGCTGGCTCCGGGCCCTGTCCGAGGAGGCGGCGCGACCGGCCCGGACGGCGGAACTGCCTCGGTGGCGCGACCTGCTCGCCGGTCCCGTCCCGCCGGTCGGCTCCCGCCCGCTGGACCCCAAGGCCGACCTCATGGCCACCACGGACACCCTGCGCGTCGAACTCCCCGCCGACCTCACCGACACCGTGCTCACCTCGGTGCCCGCCGCGTTCCGCTCCGGCGTCGACGATGTGCTGCTCACCGCCCTCGTCCTGGCGGTGGCCCGGCACCGGCGCGGCGCACCCGAGGCCGCCGCGGTCGTCCGGCTCGAAGGCCACGGACGGCAGGAGGACCTCGTCCCCGGCGCGGACCTCTCCCGCACCGTCGGCTGGTTCACCGGCGTCCACCCCGTCCGGTTCGACCTCTCCGGGATCGACGTCGACGAGGCGATCGCCGGGGGAGCGGCGGCGGGCGAAGCCCTCAAGCGCGTGAAGGAACAGCGCCACGCCGTGCCGGGCGACGGCAACGGCTACACCCTGCTGCGCCACCTCAACGACGAGACCGCGGCGGCCCTGCGCCCCCACCCGGCCGACGAGATCGGCTTCAACTTCCTCGGGCACTTCTCCTTCGACGCCCCCCGGTCCGGGCACCACGACGGCTGGACCCCCGCGCCGGAGCACCCCGAACTCGTCGCCGCCCCCGATCCCGGCATGCCCGCGCTCAGCGCCCTGGACCTGGGCGCCCTGGTGACCCGGGCCGACGACGGGCCGCGCCTCACCGCCCTGTTCACCTTCGCCACCGGCGTGCTCGGCGCCGACGAGGTCCGCGCACTGGCCGCCGACTGGCGCGCCGCCCTCACCGGACTGCGGACGCGGGCCGCCGAGGGCGCGACCGGGCTCAGCCCCGGCGACGTACCGCTGGTGACCGTCGGCCAGGCCGAACTGGACGCCTGGCAGCGGCGCTTCGGCCGGATCGACGACGTGTGGCCGCTGACCCCGCTCCAGGCCGGTCTGCTGTTCCACACGATGCTCGCGGACCCCACGATCGCCGCCTACCAGACGCAGTTCGTCTTCCGGCTCAGCGGTCCGGTCGACCCGGACCGGCTGCGCTCGGCGGGCCAGGCCCTGCTGGAGCGCCATCCCAACCTGCGCGTGGCCTTCGTGTCGACCGCGGCCGGCGAGTCCGTACAAGTGGTGGTGGAGGACGTACCGCTGCCCTGGCGGCACGTCGACCTCACCGGTGAGCCCGACGCGGAAGAGCGCCTGGAACGGATCATCACCGACGAGCGCGACGCCCCGTTCAGCGCCGACGCGCCACCGCTGCTCCGCTTCACCCTCGTCACCCGGGGACCGGACCTGGCCGACCTCGTCCTCACCGCCCATCATGTGCTGTTCGACGGCTGGTCGGTCCCGCTGATCGAGCGGGAACTGATACGGCTGTACGCGGCACACGGCGGCGCCCCGGAGCCGCCGCCCGCGCACGGCTACCGGGACTTCCTGCGCTGGCTGTCACGGCAGGACGCGGCCCGGTCGGCCGAGGCGTGGAGCGCGGAACTGGCCGGGGTCGCGGAGCCGACCCTCCTCGCGCCCGGCCCGCGCTCGGACCGCACCGGCAGCGGGCAGGTCGTCGCGGCGCTGTCCGGCGAGGAGGCCGCCGCGCTCGCCCGCAGGGCCACCGGCCTCGGCGTCACCATCAACGCCCTGGTGCAGGGCGCGTGGTCGATCGTGCTGGCCGGGCTGACCGGCCGCGACGATGTGCTCTTCGGCGTCACCGTGTCCGGCAGGCCCTCGGAACTCCCGGGAGCCGACGGGGTGATCGGCCTCTTCATCAACACCGTGCCCGTCCGTGCCACCTGCGCACCGGGCACGGACCTCGGACGCATGCTGGGCCGACTCCAGGACGCCCAGGCCGGGCTGGTGGAACACCACCACCTCGGGCTGGCCGACATCCAGCGGTCGACCGGGCTGAGCGCGCTGTTCGACACCCTCATGGTCTTCGAGTCGTTCCCCGTCGACCGGGCGGGCCTGTCCGCCGCGAGCGCGGCACCGGGTCTCGCCGTGACCGGTGTGCGCCCCTACGCCCCGCCGCACTATCCGCTGACCGTCATCGCGGCGGCCGACCCCCTGCTGCGGCTGTCCTTCCAGTACCAGCGCGACGCCTTCGACCACACCGAGGTGGAGGCCATCGCCGGCCGGCTGACCCAGGTGCTGCGGCAGATAGCCGCCGACCCGCACACCACCGTCGGCGCCCTCGACGTGCTCACCGCGGACGAGCGGGACCAGGTGCTGCACCGCTGGAACGACACCGCGGCCGAGGTCCCCCGGGAGAGCGTGACCGCCCTGTTCGCCCGGCAGGTGGCGGCGGCACCGGACGCGGTGGCGGTCGAGCACGACGGTCACGCCCTCACCTACCGCGAACTGGACGAGCGGGCCAACCGCCTGGCGCACTGGCTGATCGGGCAGGGCGTGCGGCCGGAGGCCCGGGTCGTGGTGCTGCTGCCCCGCTCGGCCGACCTGGTGGTCGCGCTGCTCGCGGTGGGGAAGGCCGGCGGCGCGTATGTGCCGGTGGACCCCGACTACCCGGCCGCCCGGGTGCGTTCCGTGGTCGAGGACAGCGGCCCGGTGCTGGTGCTCGACGTACAGCGGCTGGCCGGGGCGGACCTGTCCGGCTGCCCCGCCGACGCGCCGCGGACACCGGTCACCGCGCGGCACGCCGCCTACACCATCTACACCTCCGGCTCCACCGGCAGGCCCAAGGGCGTGGTCGTCGAACAGGGCGCGCTGGTCAACCTGCTCACCGGTATGCGGGCCCGGTTCGCGCTCACCCCTCGCGACCGGGTCCTCGCGGTCGCCACCGTCGCGTTCGACATCGCCGCTCTGGAGCTGTTCCTGCCGCTGCTGACCGGGGCGCGGGTCGTGCTGGCGGGCAAGGACGACGTCCTCCAGCCCCCGGCGCTGCTCGACCTCGTCGACCGGGCGGGCGTCACCCTGGTGCAGGCCACCCCGGCGCTCTGGCAGGAGCTGATCGCTCACGACCCGGCCCGGCTGGCCGGACTCCGCGTGATCAGCACCGGCGAGGCCCTGCCGCGTGCCCTGGCCGAGGAGCTGCGCGGCCACGCCGCCGAGGCCACCAACCTGTACGGCCCCACCGAAGCGACCATCTACGCCACCGCCGCCCGCCTCGGCCCCGGCTCCTCGGGCCTGCCCCCGTCCATCGGCGTACCCGTGGCCAACTACCGGATCCTGATCCTGGACCATGGCCTGCGCCCGGTGCCGCCGGGGGTGACCGGCGACCTCTGGATCGCCGGAGACGGCCTGGCCCGCGGCTACTTCGGCCGGTCGGCGCAGACCGCCGAGCGGTTCGTGGCGAACCCGTACGGCCCCGAGGGGTCCCGGATGTATCGCAGCGGGGACCTCGCCCGCTGGACCGGCGGCGGCGAGGTCGAGTACCTGGGCCGCTCCGACCACCAGGTCAAACTGCGGGGGTTCCGCATCGAACCCGCCGAGATCGAAGCCACGCTGGCCGGCCACGACACCATCCGCCAGGCCACCGTCGTCCTCAGGGAGGACCAGCCCGGCGAACGGCGGCTGGTGGCGTACGTGGTGCCGGAGAGTGGCGCCGAGGCGCCGCCCGCCGAGCGGCTGCGGACGCTGGTGGGCGAGCGGCTGCCCGCGTACATGGTGCCCGCGGCCGTCGTCGTGCTGACGGAATTCCCGCTCACCCCCAATGGCAAGCTGGACCGCTCGGCGCTGCCCGCGCCGGAGTTCGCGGGAGTCGCCTACCGCGCCCCGCGGTCCGGGCGAGAAGCGACGCTGTGCCGGTTGTTCGGCGAGGTGCTGGGTGCCGAACGCGTCGGGATGGACGACGACTTCTTCGCCCTGGGCGGGCATTCCCTGCTGGCCACCCGGCTGGTGGCGCGGGTGCGCGCGGAACTGGGCGTGGAGATCCCGATCCGTGCGCTGTTCACCTCACGGACCCCCGCCGAGCTGTCCGATCACTGGAACGAGATGTCGGCCCCTGCCCGCACGCAGTTGCGCAGAATGATCGAAAGGTGA	MWLAQKFAPAQPNNVVTLWNVDGGLDVPLFTSALHMVMAETDPLWVNFRRGADGLRVIARDPGTWAPFHLDVQDAPDPDDAARAAVASLTSEPFDLARDALLRVGSIRLGPDRHLVVLIFHHILTDAFGVLMLLSRRIAEVYRALYEKSDVPGCVARPAGDAAAADAAYRTSRRFADAERFWRDYLAGEPTAARLPTGVRPPEGAPPSERGPWDFLTGPLGMTTRTATVPAAERASWEGAAQRLKTSVPDLLSAAAAAYLQLMCGPSAPLHTITVNHRTGAARQALGLYSNRIPIRAAAAPEASLVELAVALGRERRGVLRHARHELALIKRATGHAAEARSPFGTIVNVFPFVEALDLAGSVARFAGGTFGLVDEIMVSLYTDGTADSDLYVRFDAPAAHYGERDLAGLADSFVPFLRAALADPARPVADISPLGAVEQRALLAACSGPAVDVPDVTLTELLDRQARATPDATAVTFEDAGLTYRELADRSGRLARTLIEAGAGPERFVAVAIPRSLDLVVALIAVLKAGAAYVPVDPEYPAARVEFMLADARPALLLVAGESAGKLPVGDVPALAVDEIPLTGGATATAPHRPDHPAYMIYTSGSTGRPKGTVITHAAIVNRLLWMQDHFRLDGTDRVLQKTSASFDVSVWEFFWPLITGATLVMARPDGHRDPAYLAEVIERARVTTLHFVPSMLVEFTAEETAARCTGLRRVVCSGEALPADVAARFDRLFGVPLHNLYGPTEAAVDVTAWRCRPEAATIPIGTPIQNTTLLVLDSGLRLVPRGVRGELYIVGAGLARGYLGRSALTAERFVACPFGPAGQRMYRTGDLARWNADGDLEFAGRADHQVKIRGFRVEPAEVEAVLAAHPGVGGAAVVARESRGADGAAQLVAYVVPKTVVGTGRQATDWDFHAGLDIAELRAFTAARLPNHLVPAAFEILDRLPLSANGKLDRGALPEPEFAARAYRPPSSDEERLLADAFAQVLGVSRVGADDDFLALGGDSIRAIQVVARARAGGLAFTPRTVFERRTVAALAVAATRDTAAPVLAELDGGGVGLVPLPPMARLIAERGPGLDRLAQWLVLELPAGVDRDGLAATVGAVLDRHDVLRSRLVDDGLLVLPPGAVDPAVLITRVGCPGHWDAPSWRQLLRTEADAALRAIDARAGRMLRLVWFDPEAGGPGRLLIAAHHLVVDGMSWRVLLPDLATAWRHIRAGTAPELPPVGTSLRRWLRALSEEAARPARTAELPRWRDLLAGPVPPVGSRPLDPKADLMATTDTLRVELPADLTDTVLTSVPAAFRSGVDDVLLTALVLAVARHRRGAPEAAAVVRLEGHGRQEDLVPGADLSRTVGWFTGVHPVRFDLSGIDVDEAIAGGAAAGEALKRVKEQRHAVPGDGNGYTLLRHLNDETAAALRPHPADEIGFNFLGHFSFDAPRSGHHDGWTPAPEHPELVAAPDPGMPALSALDLGALVTRADDGPRLTALFTFATGVLGADEVRALAADWRAALTGLRTRAAEGATGLSPGDVPLVTVGQAELDAWQRRFGRIDDVWPLTPLQAGLLFHTMLADPTIAAYQTQFVFRLSGPVDPDRLRSAGQALLERHPNLRVAFVSTAAGESVQVVVEDVPLPWRHVDLTGEPDAEERLERIITDERDAPFSADAPPLLRFTLVTRGPDLADLVLTAHHVLFDGWSVPLIERELIRLYAAHGGAPEPPPAHGYRDFLRWLSRQDAARSAEAWSAELAGVAEPTLLAPGPRSDRTGSGQVVAALSGEEAAALARRATGLGVTINALVQGAWSIVLAGLTGRDDVLFGVTVSGRPSELPGADGVIGLFINTVPVRATCAPGTDLGRMLGRLQDAQAGLVEHHHLGLADIQRSTGLSALFDTLMVFESFPVDRAGLSAASAAPGLAVTGVRPYAPPHYPLTVIAAADPLLRLSFQYQRDAFDHTEVEAIAGRLTQVLRQIAADPHTTVGALDVLTADERDQVLHRWNDTAAEVPRESVTALFARQVAAAPDAVAVEHDGHALTYRELDERANRLAHWLIGQGVRPEARVVVLLPRSADLVVALLAVGKAGGAYVPVDPDYPAARVRSVVEDSGPVLVLDVQRLAGADLSGCPADAPRTPVTARHAAYTIYTSGSTGRPKGVVVEQGALVNLLTGMRARFALTPRDRVLAVATVAFDIAALELFLPLLTGARVVLAGKDDVLQPPALLDLVDRAGVTLVQATPALWQELIAHDPARLAGLRVISTGEALPRALAEELRGHAAEATNLYGPTEATIYATAARLGPGSSGLPPSIGVPVANYRILILDHGLRPVPPGVTGDLWIAGDGLARGYFGRSAQTAERFVANPYGPEGSRMYRSGDLARWTGGGEVEYLGRSDHQVKLRGFRIEPAEIEATLAGHDTIRQATVVLREDQPGERRLVAYVVPESGAEAPPAERLRTLVGERLPAYMVPAAVVVLTEFPLTPNGKLDRSALPAPEFAGVAYRAPRSGREATLCRLFGEVLGAERVGMDDDFFALGGHSLLATRLVARVRAELGVEIPIRALFTSRTPAELSDHWNEMSAPARTQLRRMIER	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	462.95	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1656	colistin A; colistin B
BGC0000434.1|SW-163_28 # 36039 # 45512 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000434.1|SW-163_28 	36039	45512	+	Loose	1000	106.686	almE	27.13	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGATTCCCCTGTCGTACGCGCAGCGTCGGCTCTGGTTCATCAACCGCTTCGAGGGCCCGTCCCCGACGTACAACATCCCCCTGCTCCTGCGGTTCACCGGAGCGCTCGACACCGGCGCGCTGCGCGCCGCGTTCCGCGATGTGATGGCGCGGCACGAGGTCCTGCGGACGGTGTTCGGCGAGGAGGACGGCGAGCCCTACCAACGCATCCTCGACCCGGACGAGGTCGAACTGCCCTGGACGGACTGGGGCCGGGTGGCCGCCGACCGGGTGCCGGGCGTGATCTCCTCGATCATCGGCAGCTGGTTCGACCTGTCGTCCGACGCGCCGCTGCGGGGCAGCCTCGTCCGGAGCGGAGACGACGAACACCTGCTGGTCCTGGTGATCCACCACATCGCCGGGGACGGCGGGTCGCTGGCGCCGCTGGCGCGGGACGTGTCGGAGGCCTATCGCGCGCGGGTGGCCGGACACCCGCCCCGGTGGGCGGAACTGCCGGTGCAGTACGCGGACTACGCGGTGTGGCAGCGGGAGATGCTCGGAGACCTGGACGATCCGGACAGCGTCCTGTCGACCCAGGCGGCGTACTGGCGCGAGGAGCTCGCCGGGGTCTCCCCGCTGCTTCCGCTCCCCCTGGACCGGCCCCGGCCCGAGGTGGCGAGCCACCGCGGCGGATCCGTCCCGCTCGGCCTGCCGGGCGAGATCCGGGCACGTGTCGAGGAGTTGGCCCGCGCCCGCGGTATGACGGTGTCGATGGTGTTCCAGGCGGCGCTGACGGTACTGCTGCACCGGCTGGACGGCGGGGACGACGTGACGGTCGGCTCACCGATCGCCGGGCGCACCGACGAGGCACTGCACGACCTGGTGGGGTTCTTCGTCAACTCGTGGGTGCTGCGCGTCCAGGTCTCCGCGGAAGCGTCGTTCGCGTCCGTACTCGACCAGGTGCGGAGCAAGGCGCTCGCGGCGTACGAGAACCAGGACGTCCCCTTCGAGCGGCTCCTCGAACTGCTGCGGCCGGAGCGGTCCACCGCCCACCACCCGCTGTTCCAGACCGTGCTGGCCTGGCAGAACAACACACCGCCGGAACTGGAGATGCCCGGTGTGACGGTGTCGATGGAGCCCATCCCGACCGGCACCGCCAAGTTCGACCTGTTCTTCAACATGGCGCCGGACGAGTCCGACGGCTCGGTGACGGGCGAGATCGAGTACGCCACCGACCTGTTCGACCGCTCGACGGTGGAGGAGATCGCCGCCCGGTTCGTACGGGTGGTGGAGCAGGTGGTCGCCGACCCGGAGATCACCGTCGGCGCCGTCGACGTACCGGCCGTCGGCGGCCGGGAGCACACCACCACGGCCGACGAGGCCGCCGCGGGCGATGCCGCGCCCGACGCCGCGCGCCGCCCGCTCGACGCGGCGGAGCGCCACAAGATCCTCGTCGAGTGGAACGACACCGCGCGTGAGGTGCCCTGTCCCGGGCCGATCCATGTGCTGTTCGAGGAGCAGGCCGCCCTGCGCCCGGACGCGATCGCGGTGCGCTGGACCGGCGGCACCATGACCTACCGCGAGCTGAACCAGCGGGCGAACCGGATCGCCTGGGACCTCAAGGAACGCGGCGTCGGCCCGGAGACGGTGGTCGGCATCGGCATCCGCCGCGGCCCGGTCATGGTCGCGGCGGTGTTCGGCGTGCTCAAGGCGGGCGGCGCCTATCTGCCGCTCGAACCGTCGTCCCCCGCCGAACGCGTCGCCGGCATGCTCGCCGACACCGGGGCGGACACCGTGCTGACCACGGCGGACACCGAACTCCTGGCCCTCCCCGACGGTGTCACCCGCATCGAGGTCGCCGGTGAGCAGGACCCGCCGCCCCCCGCGGCCGAGGGCGACCCGGAGCCGTCCGCCGGGCCGGACACCACCGCGTACGTCATCTTCACCTCCGGCAGCACCGGTAAGCCCAAGGGCGTGGTGATGACCCACCGGCCGCTGCACAACCTGCTCAACTGGTGCTTCCGCACCTTCGGTTTCGGACCCGACGACACCGGCCTGTGCCTCACCTCGCTGGGCTTCGACCTGTCGGTCTTCGACATCCTCGGCCTCCTGGGCTGCGGCGGCTCGCTGTACATCGCCGACGAGGCCCAGCAGCGCGATCCCTCGCTCCTGCTCGACCTGCTGCTCACCGAGCCGATCACCTTCTGGAACTCGGTGCCGACCACGCTCAACCAGCTGCCGCCCCTGCTGTCCCGGAAGGACACCTGGGAAGGGACCGGCAGGCTGCGCCTGGTGTTCCTGTCCGGCGACTACACCCCGCTGCCCCTGCCGGACGAGATCCGCGCGGTGTTCGACCGCGCCGAGATCGTCAGCCTCGGCGGGGCGACCGAGGCCACGGTGTGGTCCAACTACTTCCGCGTACGTGAGATCGACCCGGCCTGGCGCAGCATTCCCTACGGCCGGCCCATCGACAACGCGCGCTACTACATCCTCGACGACGACATGCAGCCGTGCCCGGTCGGCGTCGAGGGCGACCTCTACATCGGCGGGGACGTGCTGTGCGCCGGATACGCCAACCGCCCGGAGCTGACCGCGGAACGCTTCCTCCGCGATCCGTATCCCCACCGGGACGGCGACCGCCTCTACTGGACCGGCGACCGGGCGAGCTTCTACCCCGACGGAAACATCTGCTTCCAGGGCCGCGCCGACAACCAGGTGAAACTGCGCGGCTTCCGCGTCGAGCCCGGCGAGATCGAAGCCACCCTGGTCCGCCACCCCGCCGTCCGCCAGGCCATCGTCACCCTGCGCGAGGACCGGCCCGGCGACAAGCGGCTGGCCGCCTACGTCGTCGCGGACACCGGCGCGCTGGACACCGCGGGCGGGGCACAGGAGCAGATCGAGGAGTGGCACGAGGTCTATGACCAGGGGTACGCCGACGAACCCGACGTGCCGTTCGGCGAGGACTTCACCGGCTGGAACAGCGCCTTCACCGGCGACCGCATCCCGATCGGGGAGATGCGCGCCTGGCGGGACGCCGCGGTGCGCCGCGTCCTGGACCACTCGCCGCAGTGCGTTCTCGAACTCGGCGTCGGCTCCGGCCTGTTGCTCGCCCATCTCGCGGGCCGGGTGGAGCGGTACTGGGCCACCGACTTCTCCGCGGCGGTCGTCGAGCGGCTGCGCCGTCAGGTGGCGCGGGCCGGTCTGGCCGACCGCGTCGAGCTGCGCTGCCAGGCCGCCGACGACACCTCCGGCCTGCCCCGGGGCGAGTTCGACACCGTGCTGCTCAACTCGGTGGTGCAGTACTTCCCGAACGAGCACTACCTCCGCCAGGTCCTGGACGCCGCGTGGGACATGCTCGCGCCGGGTGGCCGGATCGTCCTCGGCGACGTCCGCCGGGCCGCCTCCCTGCCGGTGCTCCAGGTCGCCGTCCAGCGGGCCAGGCACCCGGAGGCCACACCGGAGGTGCTGCACAGCGCCGTGGACCAGGCCGTACTGCTGGAGAAGGAACTCGTCGTCGACCCCGAGTGGTTCCTGCGCTGGGCCGACCACGCCGACGGGGCCGCCGTCGATGTCCGGGTCAAGGACGGCGACGCGCACAACGAACTCACCGGGCACCGCTATGAGATCGTGCTGCACAAACCGGGTGGCACCCAGCCGGCGCAGTCCGTGGCCGGTGTTCCCGCCCTGGCCTGGGACGGTGATCTCGACCGCTGCGCCGCGCGGGTGGGCGCACAGGACGCGGCGGTCGTCCGCGTCACCGGTGTGCCGAACGCCCGTCTGACCGACGAGATCGCCGCCGCCCGGGAGCTCGGCGAGGAGCAGCCCGGCACGTTGGTGCCACCGGCTCTCGACCCGCCCGTGATCCGCGCCTGGGCCGAACGGCACGGCTGGGACGCGCTGGTGACGCTGTCGGCCACCGCGGTCGACGGGGTGGACGTGCTCGTCTTCCGGGACGGACCGGCGGCCGGCCGGACCCTGAGCGGGGTGTACCTGCCCGGCCGGGGCGACCGGGCGCCGGTCAACAACCCGGCCGTCGCGAACGGGATAGCCGCGCTGCTGCCCGCCCTCCGCGCGCACCTGCGGGAGAGCCTGCCCGCGTACATGGTGCCCGCCGCGATCGTGCCGATCGCCGGGGTGCCGCTGACCGACAACGGCAAGCCGGACCGACGGGCGCTGCCGGTGCCCGACTACGCCGCGGGCAGCGGCGGACGGGTCCCGTCGACGCCGGAGGAGGAGTTGCTGTGCACGCTGTTCGCCGCCGTACTCGGCGTCGACCGGGTCGGCGCCGACGACAACTTCTTCTCCATCGGCGGCCATTCGCTGCTGGCCACCAAGCTGGTCAGCCGCATCCGCGCGGTGCACGGTGTGGAGATCCCGATCCGCCTGGTGTTCCAGGCCTCCACCCCCGCCGAGCTGGCGGTCCACCTGACCACCGCGACCGCCGTCCGGCCGCCGCTGGTCCCCCGGGCCAGGCCGGAGCGGCTGCCGGTCTCCTTCGCACAGCGACGGCTGTGGTTCATCCAGCGGCTCGAAGGGCCGTCGGCCACCTACAACGTCCCGCTGGGCCTGCGGATGCGCGGCGACCTCGACGCGGCGGCGCTCCGCGAGGCCATGGACGACGTCGTGGAGCGGCACGAGTCGCTGCGCACGGTCTTCGGCGAGGATGCCGGGCAGCCGTACCAACGAGTCCTCGCGCCGGACGAGGTCGAAGTGGGGTGGGAGGAACGCGAGGTCACCGAGGCCGAACTGCCGGCCGCGCTGCGCGAGGCGGCCCGCCGCCCCTTCGACCTGGGACTCGAGATCCCCATCCGCGCGTGGCTGTTCCGGCTCGGCGCCCATGAGTGGATGTTCCTGATCAGCGCGCACCACATCGCCGCGGACGGATGGTCGGCGCGCCCGCTCGCCTCGGACCTCGCCACGGCCTACGAGGCCCGGTGCGCGGGCGGGCGGCCGGAGTGGAAGCCGCTGCCGGTGCAGTACGCGGACTACACCCTGTGGCAGCGCGATCTGCTCGGGGACAGCGACGACCCGGACAGCCTGTACCGGCGCCAGCTGGACTACTGGACCACCCAGCTGACAGACCTGCCGGCCACCATCGACCTGCCCACCGACCGGGCGCGGCCCGCGGTGGCGTCCTACGAGGGCGACGCGGTCTTCATCGATATCGACGAACAACTCACCGCAAATATCCGGTCGTTGGCCCGGGAGACCGGTGCCACCGTGTCGATGGTGCTCCAGGCGGGACTGGCCGCGATCCTCACCCGGCTGGGCGCGGGCACCGATGTGCCGCTCGGCGCCCCGATCGCGGGCCGCACGGACGATGCGCTGGCCGGCCTGGTGGGCTTCTTCGTCAACACCTGGGTGCTGCGGGCCGACACCTCCGGCGACCCCACCTTCGCCGACCTCGTCGGCCGGGTGCGGCAGCGGAGCCTGGCCGCCTACGACAACCAGGACGTCCCCTTCGAGCACCTGGTCGAGGTCCTGAACCCGGTGCGCTCGCCCGCCCACCACCCGCTGTTCCAGGTGCACCTCGCACTCCAGAACAACACCCCGGGGAACTACTCCCTGCCGGGCCTGACGCTCTCCGAGGAGATCTTCAGCGCGGGTGTCTCGCGCTTCGACCTGTTCCTCAGCCTCACCGAACACGATGGGGACCGGCCGCACATCTCCGGCTTCGCCGAGTACGCGACCGAGCTCTTCGACGCGGGCACGATCACCGCGCTGCTCGACCGCTGGACGCACTTCCTGCGACAGGCGGTCGCCGCGCCGGACACGCCCCTCGGGGCGGTGGACATCCTCATGGACGGAGAGTCCGCGACACTGGCCCGGTGGGGCGGCCGCGGCCGTGCGGAGCGGCTCGAGGCCGGAACCATCCACCAGCGGTTCTCCGCCGTCGCCGCCGAAGACCCGGACGCCACCGCGCTGATCTCCGCCGACGGCTCGGAACGCTGGACCTACGCCGAGCTGGACCGCTGGTCCAACCGCATCGCCCACCACCTGTGCGAGCGCGGCGCCCGCCCGAACGGCCGCGTGGCGGTGAAGCTCGACCGCTCGCCGCTGATGGTGGCGGCCCTCCTCGCGGTCCTGAAGGCGGGCGCGGCCTTTGTGCCCGTCGACCCCTGCTACCCCGCCGACCGCGTCGACTTCATGCTCGCGGACGCCGCGCCCGATGTCGTCGTGGACCACACCCTCGCCGACCTCGACCTGTCCGGTCATCCGGATTCCGCGCCCGAGATCAAGGGAGTCGGGGAGCAGAGCGGCGCGTATGTGATGTTCACGTCCGGCTCCACCGGTCGCCCCAAGGGCGTCGAGGTGACCCACCGCAACGTCGTCGACTTCGTACTCGACGCGTGCTGGGCGGGCGCCGCGCACCGCCGTGTGCTGTTCCACACGACGTTCACCTTCGACCCGCTGAACTACGAGCTGTGGGTGCCCCTGTTCAGCGGTGGCGCCGCGGTGCTGGCCCCCGCGGGCCAGCTGGACACCGCCGAACTCGCCGGTGTCATCGCCGACCGCAAGGTGACCGGCCTGTGGCTGACCACCGGGCTGTTCGTCGTGATGGCCGAGCAGCACCCGGAGTGCTTCGCCGACGTCGCCGAGGTGTGGACCGGCGGCGAGGTGCTGCCGCCCTCGGCGGTCCGCAAGGTCCTGGCGGCCTGCCCCGGCCTCGCCGTGGTCAACGCGTACGGCCCGACGGAGGCCACCACCTTCGTCTCCGGCCACCGGATCGCCTCGCTGGAGGAGTGCACCGACCCGCTGCCCATCGGCGGGCCTTTGCAGAGCACCGAGTTCCGGGTGCTCGACGCCGCCCTGCGGCCGGTTCCGTCCGGCGTTGCCGGGGAGCTGTACATCGGGGGCGAAGGCGTGGCGCGCGGATATGTCAACCGACCGCTCCTGACCGCCGAGCGGTTCGTCGCCGACCCGTACGGGGCGCCGGGCGCGCGGATGTACCGCACCGGCGACCTGGTGCGCTGGAACACCGCCGGGCACCTGATGTTCCTCGGCCGGGTGGACGACCAGGTGAAACTCCGCGGCTTCCGCGTCGAGCCGGGGGAGATCGCCACGGCGTTGCGCAGGCGCGAGGGCGTGGTGCAGGCGGTCGTGACCGTACGCGAGGACCGCTTGGGCGAACGGCGCCTGGTGGCGTACGTGGTGCCCGACGCGTCGGTCGACTCCGACCACGAGGCCGTCCTGCACCTCGGCGAGTGGCAGGAGATCTACGACTCCATGTACGGCGAGGCCGAAGTGGGCCTGGACGGGGTCGGCGAGGACTTCACCGGCTGGAACAGCTCCTACACCGGTCAGCCCATCCCGCTGCCGGAGATGCGGGCGTGGCGCGACGCCGCGGTGGGCCGGGTGCGCGCCCTGCGGCCGCGGCGCGTGCTGGAGATCGGCGTCGGGTCCGGCCTGCTCATGGGGCCGCTCGCCCCCGAGGCAGAGGAGTACTGGGGCACCGACTTCTGTGTCCCGGTGGTCGAGAGGCTGCGCGCCCAGGTCGCCGCCGAGCCCCGGCTCGCGGAGAAGGTGACGCTGCGCGTCCAGGGCGCCGACGAGGCCGGTGACCTTCCCACCGGGCACTTCGACACAGTGATCCTCAACTCGGTCGTGCAGTACTTCCCGGACGCCGGCTATCTCGAGCGGGTGCTGGATGTCGCGCTGCGCAGCCTGGCCCCGGGCGGGCGGATCGTGGTCGGCGATGTCCGCAGCCACCACACGCTGCGGGCGTTCACCGAGGCCGTCCACCGCGCGCGGCGCCCGGAGAATCGGGCGGCCGCCGTACAGGCCGCGGTCGAGCGCGCGGTCCTGGACGAGAAGGAATTGGTCATCGCCCCCGACTTCTTCGTGCGGTGGGCCGAGGCACACCCGGACGTCACCGCCACCGACATCCGGCTCAAGCAGGGCACCGCGCACAACGAACTGACCCGCCACCGCTACGAGGTCGTCCTGCACAAGGGCCCCCTCCAGGCCCTCGACCTCGCGGGTCTGCCGATGGAAACCTGGGGCGTCGATGTCCATGAACTGGACGGCGTCGCTGGCGCGTTGGCCCGGCACGGCGGGAAGATCCGCCTGACCGGGGTGCCGAACGCCCGGCTGGCAACCGAGAAGGGCGAATGGGGCGGCCAGATCGACGACCGCACCGCACTCGACCCGGCCGACCTGGAGGCGTGGGGCGCCGAGCGGGGCTACGCGGTGTACTGCACCTGGTCGGCGGAGTCACCGGACCGCTTCGAGGCGGTCGTGGTGCCCGATGTGGATGCCACCGCCTGCGACGGAATCTACCGCCCCACCCGTGGCCGCACCGGACGGCTGGTGAACTCGCCCGCGCTGTCCCGCGGCGCGTCCCGGCTGCCGTCGCGCCTGCGTGAGCAACTGGCCCGGGAACTGCCCGACTTCATGATGCCGAGCGAAATCGTCCTGCTCACCGAACTGCCCCTCAACGACCACGGAAAGGTGGACCGCGCCGCGCTGCCCGACCCCGACCCGAGCGGCGGCGCCTACCGCGCCCCGCGCACCTCGCGCGAGAAGGCCCTCGTCGGCCTGTTCGCCCAGGTGCTGGGCCTGGACCGGGTCGGGATCGACGACGACTTCTTCGCCTGCGGCGGCCACTCGCTGCGGGTGACCCGTCTCGTCTGGCAGATCCGCGAGACGATGGGCATCGACGCGCCCATCAGGACGGTGTTCCAGTATCCGACGGTCGCCGAGCTCGCCGAGCAGCTGTCCATGGACACGGAGGTGACGACCTTCGAGGACCCGTTCGCCGTCGTCCTGCCGATCCGCACCGAGGGAGAGAACCCCCCGCTGTGGTGGCTGCATCCCGGCGGCGGGCTGAGCTGGCCGTACATGAGCTTCGCCCGGCACATCGACGCGTCGTGGCCGCTCTACGGCATCCAGGCGCGCGGCTTCGACCGGGTCACCCCGCCGTCGTCCTCCATCGAGGAGATGATCGACGACTATGTGGGCCAGGTGCTCGAGGTCCAGCCGGAGGGCCCGTACCACGTGCTGGGCTGGTCGTTCGGCGGCACCCTCGCCCAGGCGGTGGCCGCGGAGCTCCAGCGTCGCGGGCACGAGGTGGCGCTCCTCGCGATCCTCGACGCCGCGCCTGCCAACTACTTCTCCGGTCTGGAGACGTTCAACGAGGACATGATCCGCCCCTTCCTCGCCGCCTACATGGAACACCTCCAGGGGATGGAGGGCTACGAGTTCCTCGTCGAAACCGCTTCGTCGATCTTCGTGAAGCACATCGAGCAGATGCAGCGCTACACCTCGCCGCAGTACCGCGGCGAGGTCGTGTTCTTCAACGCGCTCCTCGATCTCGACACGCGTGACCTGCGCCGGCTCGACGAGGAGATGGACGCGCGGTGGCACCGCTACATCGACGGGCCGGTGCACCGCGTGGACGTGGCCTGCGCACACAACGAGATGTACTGGCCGCGGAACGCCGCCGAGGTCAGCCGTGTGATCAACCGGATGCTTCGGGAGCTGCGACGCCCGTGA	MIPLSYAQRRLWFINRFEGPSPTYNIPLLLRFTGALDTGALRAAFRDVMARHEVLRTVFGEEDGEPYQRILDPDEVELPWTDWGRVAADRVPGVISSIIGSWFDLSSDAPLRGSLVRSGDDEHLLVLVIHHIAGDGGSLAPLARDVSEAYRARVAGHPPRWAELPVQYADYAVWQREMLGDLDDPDSVLSTQAAYWREELAGVSPLLPLPLDRPRPEVASHRGGSVPLGLPGEIRARVEELARARGMTVSMVFQAALTVLLHRLDGGDDVTVGSPIAGRTDEALHDLVGFFVNSWVLRVQVSAEASFASVLDQVRSKALAAYENQDVPFERLLELLRPERSTAHHPLFQTVLAWQNNTPPELEMPGVTVSMEPIPTGTAKFDLFFNMAPDESDGSVTGEIEYATDLFDRSTVEEIAARFVRVVEQVVADPEITVGAVDVPAVGGREHTTTADEAAAGDAAPDAARRPLDAAERHKILVEWNDTAREVPCPGPIHVLFEEQAALRPDAIAVRWTGGTMTYRELNQRANRIAWDLKERGVGPETVVGIGIRRGPVMVAAVFGVLKAGGAYLPLEPSSPAERVAGMLADTGADTVLTTADTELLALPDGVTRIEVAGEQDPPPPAAEGDPEPSAGPDTTAYVIFTSGSTGKPKGVVMTHRPLHNLLNWCFRTFGFGPDDTGLCLTSLGFDLSVFDILGLLGCGGSLYIADEAQQRDPSLLLDLLLTEPITFWNSVPTTLNQLPPLLSRKDTWEGTGRLRLVFLSGDYTPLPLPDEIRAVFDRAEIVSLGGATEATVWSNYFRVREIDPAWRSIPYGRPIDNARYYILDDDMQPCPVGVEGDLYIGGDVLCAGYANRPELTAERFLRDPYPHRDGDRLYWTGDRASFYPDGNICFQGRADNQVKLRGFRVEPGEIEATLVRHPAVRQAIVTLREDRPGDKRLAAYVVADTGALDTAGGAQEQIEEWHEVYDQGYADEPDVPFGEDFTGWNSAFTGDRIPIGEMRAWRDAAVRRVLDHSPQCVLELGVGSGLLLAHLAGRVERYWATDFSAAVVERLRRQVARAGLADRVELRCQAADDTSGLPRGEFDTVLLNSVVQYFPNEHYLRQVLDAAWDMLAPGGRIVLGDVRRAASLPVLQVAVQRARHPEATPEVLHSAVDQAVLLEKELVVDPEWFLRWADHADGAAVDVRVKDGDAHNELTGHRYEIVLHKPGGTQPAQSVAGVPALAWDGDLDRCAARVGAQDAAVVRVTGVPNARLTDEIAAARELGEEQPGTLVPPALDPPVIRAWAERHGWDALVTLSATAVDGVDVLVFRDGPAAGRTLSGVYLPGRGDRAPVNNPAVANGIAALLPALRAHLRESLPAYMVPAAIVPIAGVPLTDNGKPDRRALPVPDYAAGSGGRVPSTPEEELLCTLFAAVLGVDRVGADDNFFSIGGHSLLATKLVSRIRAVHGVEIPIRLVFQASTPAELAVHLTTATAVRPPLVPRARPERLPVSFAQRRLWFIQRLEGPSATYNVPLGLRMRGDLDAAALREAMDDVVERHESLRTVFGEDAGQPYQRVLAPDEVEVGWEEREVTEAELPAALREAARRPFDLGLEIPIRAWLFRLGAHEWMFLISAHHIAADGWSARPLASDLATAYEARCAGGRPEWKPLPVQYADYTLWQRDLLGDSDDPDSLYRRQLDYWTTQLTDLPATIDLPTDRARPAVASYEGDAVFIDIDEQLTANIRSLARETGATVSMVLQAGLAAILTRLGAGTDVPLGAPIAGRTDDALAGLVGFFVNTWVLRADTSGDPTFADLVGRVRQRSLAAYDNQDVPFEHLVEVLNPVRSPAHHPLFQVHLALQNNTPGNYSLPGLTLSEEIFSAGVSRFDLFLSLTEHDGDRPHISGFAEYATELFDAGTITALLDRWTHFLRQAVAAPDTPLGAVDILMDGESATLARWGGRGRAERLEAGTIHQRFSAVAAEDPDATALISADGSERWTYAELDRWSNRIAHHLCERGARPNGRVAVKLDRSPLMVAALLAVLKAGAAFVPVDPCYPADRVDFMLADAAPDVVVDHTLADLDLSGHPDSAPEIKGVGEQSGAYVMFTSGSTGRPKGVEVTHRNVVDFVLDACWAGAAHRRVLFHTTFTFDPLNYELWVPLFSGGAAVLAPAGQLDTAELAGVIADRKVTGLWLTTGLFVVMAEQHPECFADVAEVWTGGEVLPPSAVRKVLAACPGLAVVNAYGPTEATTFVSGHRIASLEECTDPLPIGGPLQSTEFRVLDAALRPVPSGVAGELYIGGEGVARGYVNRPLLTAERFVADPYGAPGARMYRTGDLVRWNTAGHLMFLGRVDDQVKLRGFRVEPGEIATALRRREGVVQAVVTVREDRLGERRLVAYVVPDASVDSDHEAVLHLGEWQEIYDSMYGEAEVGLDGVGEDFTGWNSSYTGQPIPLPEMRAWRDAAVGRVRALRPRRVLEIGVGSGLLMGPLAPEAEEYWGTDFCVPVVERLRAQVAAEPRLAEKVTLRVQGADEAGDLPTGHFDTVILNSVVQYFPDAGYLERVLDVALRSLAPGGRIVVGDVRSHHTLRAFTEAVHRARRPENRAAAVQAAVERAVLDEKELVIAPDFFVRWAEAHPDVTATDIRLKQGTAHNELTRHRYEVVLHKGPLQALDLAGLPMETWGVDVHELDGVAGALARHGGKIRLTGVPNARLATEKGEWGGQIDDRTALDPADLEAWGAERGYAVYCTWSAESPDRFEAVVVPDVDATACDGIYRPTRGRTGRLVNSPALSRGASRLPSRLREQLARELPDFMMPSEIVLLTELPLNDHGKVDRAALPDPDPSGGAYRAPRTSREKALVGLFAQVLGLDRVGIDDDFFACGGHSLRVTRLVWQIRETMGIDAPIRTVFQYPTVAELAEQLSMDTEVTTFEDPFAVVLPIRTEGENPPLWWLHPGGGLSWPYMSFARHIDASWPLYGIQARGFDRVTPPSSSIEEMIDDYVGQVLEVQPEGPYHVLGWSFGGTLAQAVAAELQRRGHEVALLAILDAAPANYFSGLETFNEDMIRPFLAAYMEHLQGMEGYEFLVETASSIFVKHIEQMQRYTSPQYRGEVVFFNALLDLDTRDLRRLDEEMDARWHRYIDGPVHRVDVACAHNEMYWPRNAAEVSRVINRMLRELRRP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	567.81	gnl|BL_ORD_ID|4935|hsp_num:0	5928			162	1407	colistin A; colistin B
BGC0000434.1|SW-163_29 # 45547 # 45759 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.676	BGC0000434.1|SW-163_29 	45547	45759	+	Loose	400	26.9498	tetB(P)	39.29	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGCACCAATCCGTTCGACGACGAGGACGGCCGGTTCCATGTGCTGGTCAACGACGAGGACCAGCACTCGCTCTGGCCCGCGTTCGCCGAGGTCCCTGCCGGCTGGCGCGCGGTCTTCGGTCCGGCCGGACGGGCGGAGAGCCTGGCGTATGTGGAGGAGAACTGGACCGATATGCGTCCCCGAAGCCTCCAGCAGGCCATGGACGCGTGA	MSTNPFDDEDGRFHVLVNDEDQHSLWPAFAEVPAGWRAVFGPAGRAESLAYVEENWTDMRPRSLQQAMDA	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	10.74	gnl|BL_ORD_ID|737|hsp_num:0	804			1374	1458	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000434.1|SW-163_30 # 45903 # 46358 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.623	BGC0000434.1|SW-163_30 	45903	46358	+	Loose	400	43.5134	ParR	28.89	3005068	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGGACCTGAGGAGCCGATGTCGTAGGGAAGGAGTACCGCGATTACTCGTCGTCGAGGGAGGTGCGCAGCCGCCGGTCAGCATTGACCCGGTCGAGGACTGGGTCCGGCCACCGATCTCCCGCGACGACCTGGAGGCTCGGGTCAGAGCCTTACAGAACCGGTTCAACAGTCGTAGGGTACCGACACTCGACTCGGCGGGAAATCTGAGATTCGGCCGTCACTCGATCACCATCTCCACCACTCAGACCGAGCTCATGAGGCTGCTCATCGAGCGCTTCGACGAAGTGGTGTACCGCAATGAGTTCGTGCACTGTCTGGCCTCACGGATGCCGACGCTGACCAGGAACTCGCTCGACCTGCACATCATGCGGCTCCGCCGCCGACTCCTGCCGATCGATCTGTCGATCCGGACCGTATGGGGTCGGGGATACATGCTGGAGAAGGCGCAGGCCTGA	MDLRSRCRREGVPRLLVVEGGAQPPVSIDPVEDWVRPPISRDDLEARVRALQNRFNSRRVPTLDSAGNLRFGRHSITISTTQTELMRLLIERFDEVVYRNEFVHCLASRMPTLTRNSLDLHIMRLRRRLLPIDLSIRTVWGRGYMLEKAQA	MDCPTLSKVLLVEDDQKLARLIASFLSQHGFEVRQVHRGDAAFAAFLDFKPQVVVLDLMLPGQNGLQVCREIRRVANLPILILTAQEDDLDHILGLESGADDYVIKPIEPPVLLARLRALMRRHAPLPASPESLTFGKLNIDRRRREAELEGLGIELTTMEFELLWLLASQAGEILSRDEILNQIRGIGFDGLNRSVDVCISKLRNKLKDNPREPVRIKTVWGKGYLFNPLGWEL	64.26	gnl|BL_ORD_ID|2791|hsp_num:0	3806			297	684	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000434.1|SW-163_31 # 46463 # 47401 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000434.1|SW-163_31 	46463	47401	-	Loose	400	27.7202	vanR gene in vanD cluster	33.33	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGTCTTCGAACTCCGGCAACGAAACCGTCATCGTCGGGGCCGGCCCCGCCGGGCTCACCGCGGCGCTCGCCCTGAGCAGATACCGCCACCCCGTGGTCCTCGTGGACAGCCGTCAGGCACCGCGCAACCACCTGTCGAGCGGTGTGCACGGGCACATCGGTCTGGACGGTGTCCCTCCCGCCGAGATCCGGTCCCGCACCTTCGAGGAACTCTCCCGGTACGCGACCACCGACATCCTGGAGGCCGATGTCGACGGCGTACGCACGGGGGACGACGGCCGGTTCCGCGTCGCCCTCGGCAACGGCGACACCCTGGAGGCTTCGACCGTCCTGCTCGCCACCGGTGTCATCGACGTCCACCCGGCCGACGTGGACGGGTTCTCCGCCTGCTGGGGCCACACCGTCATCCACTGCCCGTTCTGCCTCGGCGAGGAGAACGCCGACCGCCGCTGGGGCCATGTCACGGACAACGCCCAGCTCGCCGCCCTGTCGGCGGTGGCGATGCGCGCGTGGAGCAAGGACACCGTCGTCATCTGCCCCGAGTCGATGCCCGGCCTCGACGAGGCCCGCACGACCGCGCGTGGCTTGGGCGGCGACATCGTGGCGGGCACGATCCGCCGTCTGCACCACCACGACGGATCGCTGTACGCGGTCGAGTTCGACGACGGCCGCACCCTGGAGCGCGACACCCTGGTGTGGACGCCGGAGCAGCGGCAGCAACCCGTTATCGCAAGGGCCGTCGACGAGCTGAAACTGTCCGTCGACGACGGCGGGTTCCTGAGCGTCGACGACACGCAGTGCACCAACGTTCCGGGCCTGTACGCGGCCGGGGACGTGGCCTCCCGGTGGAAGCAGTCGTTCACCTCGGCGGCCGCGGCGGGTGCCGCCGCCGCCGAGGCCATGCACGCCACGGCGGTCTTCAGCGCCATCCAGCACTGA	MSSNSGNETVIVGAGPAGLTAALALSRYRHPVVLVDSRQAPRNHLSSGVHGHIGLDGVPPAEIRSRTFEELSRYATTDILEADVDGVRTGDDGRFRVALGNGDTLEASTVLLATGVIDVHPADVDGFSACWGHTVIHCPFCLGEENADRRWGHVTDNAQLAALSAVAMRAWSKDTVVICPESMPGLDEARTTARGLGGDIVAGTIRRLHHHDGSLYAVEFDDGRTLERDTLVWTPEQRQQPVIARAVDELKLSVDDGGFLSVDDTQCTNVPGLYAAGDVASRWKQSFTSAAAAGAAAAEAMHATAVFSAIQH	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	134.48	gnl|BL_ORD_ID|1052|hsp_num:0	1004			42	195	vancomycin; teicoplanin
BGC0000434.1|SW-163_23 # 23300 # 24787 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0000434.1|SW-163_23 	23300	24787	-	Loose	200	25.0238	Escherichia coli soxS with mutation conferring antibiotic resistance	31.71	3003511	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGGTGTCCGCTTCCGCCGCCATCACGGGATTCACGAAAGAACTAGGTAAGACATGGGGGGCGCCGGGCGGTCGGGTCATGACGATTTATCACGGTGCCAGTGAAAGGAGTGTCCGGATGAGTTTGTCACTCGACCTCACGGACCCGGCCACATTCGTCGAGCACGACCCGCACGCGTTCTGGCGGCGGGTGCGCCGGGAGCGGCCCGTCCACTGGCACCCGGCCGCCTCGGGACGCCCCGGTTTCTGGGTAGTCGCCGGGTACGAGGACGTCCTGTCCTGCCACGACGACTGGAAGCGGCTGAGCTCCGCCCGCGGCAACGTCCTGGACGTACTGCTGCACGGCGGCGACTCGGCGGGCGGGAAGATGCTCGCGGTCACCGACCGCCCCCGGCACCGGCAGTTGCGCAGCATCATGCTGCGCGCCTTCTCCCCCCAGGTGCTGGGCGAGGTGGTGCGCAGGGTCGAGCAGCGCACGGCGGAACTCATCGGGAGGGTCACCGAGCTGGGAACGTTCGACTTCGCCGCGGAGGTCGCCGAGCACATCCCGATGAACACCATCTGCGATCTGCTGTCCGTTCCCGAACAGGACCGCAAGAGCCTGCTCGGGTGGAGCAAGGCGGCGCTGGCGTCCGACGCCCCGGGCGGCGCGCAGCTGGACGCGCTGGAGGCCCGCAACGAGATCGTGCTCTATCTGATGGACCTGGCCTTCGAGCGCCGCGCGAACCCGGGCGACGACGTGATCAGCATGATCGCCGGAGCCGAGGTCGACGGCCGGCCACTGACGCCGGAGGAGATCGCGCTCAACTGCTACAGCCTGATCCTCGGAGGGGACGAGTCGTCGCGGATGACCGCGATCAGCTCGGTCCTCGCCTTCACGCAGTACCCCGAGCAGTGGCGGGGGCTGCGCGAGGGGAGCATCTCCGTGGACACCGCGGTGGAGGAACTCCTGCGCTGGGCGACACCGGGTATGCACTTCGCGCGCACGGCCCTGTGCGACTTCACCCTGCGGGGCGAGCGGGTGCGCGCGGGCGACATCGTGACGCTCTGGACCATCTCCGCCAACAACGACGAAACCGTCTTCGCGTCCCCGCGTGACCTCGACCTGTCCCGCGCCCCGAACAAGCACCTCACCTTCGGCCACGGCCCGCACTTCTGCGTCGGCGCGGCGCTGGGCCGGGCCTCGGTGAGCGCACTGGTACGCGGTCTCGTCGCGCACGTGGACAGGATCGAACCCGGCGGGGAGCCGTCCCGGATCTACTCCACCTTCCTCTACGGCCACAGCAGGCTGCCCGTCACCTTCCATCCGCGCTCCTTACGAAAGGCAACGCGATCATGCTTGACGGATTCGTCCCCTGGCCCGGCCACCTCGCGGAGAGCTACCGCCGACGGGGACTGTGGCTGGGGCGGCCGCTCGGCGACCTCCTGCTCGAATCCTGCGAGCGGCACGCCGACCGCGTGGCCGTCGTCTGCGACGAGGAGCGGCTGA	MVSASAAITGFTKELGKTWGAPGGRVMTIYHGASERSVRMSLSLDLTDPATFVEHDPHAFWRRVRRERPVHWHPAASGRPGFWVVAGYEDVLSCHDDWKRLSSARGNVLDVLLHGGDSAGGKMLAVTDRPRHRQLRSIMLRAFSPQVLGEVVRRVEQRTAELIGRVTELGTFDFAAEVAEHIPMNTICDLLSVPEQDRKSLLGWSKAALASDAPGGAQLDALEARNEIVLYLMDLAFERRANPGDDVISMIAGAEVDGRPLTPEEIALNCYSLILGGDESSRMTAISSVLAFTQYPEQWRGLREGSISVDTAVEELLRWATPGMHFARTALCDFTLRGERVRAGDIVTLWTISANNDETVFASPRDLDLSRAPNKHLTFGHGPHFCVGAALGRASVSALVRGLVAHVDRIEPGGEPSRIYSTFLYGHSRLPVTFHPRSLRKATRSCLTDSSPGPATSRRATADGDCGWGGRSATSCSNPASGTPTAWPSSATRSG	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	462.62	gnl|BL_ORD_ID|1975|hsp_num:0	2066			120	243	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan; enrofloxacin
